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linked together by a-1 ,4-glycosidic bonds with a-1 ,6-glyco-
sidic branches occurring every 12-25 glucose moieties. The 
branches in amylopectin, the major component in starch, are 
arranged in clusters at regular intervals. Adjacent chains CROSS REFERENCE TO RELATED 
APPLICATION 
The present application claims the benefit of U.S. Provi-
sionalApplication No. 61/673,476, filed Jul. 19,2012, herein 
incorporated by reference. 
5 within the clusters form double helices and the clusters orga-
nize into crystalline lamellae that make starch water-in-
soluble. The structures of amylopectin (1) and amylase (2) are 
shown below. 
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TECHNICAL FIELD 
The presently-disclosed subject matter relates to glucan 
phosphatase polypeptide variants, and in particular, Starch 
Excess 4 (SEX4) glucan phosphatase polypeptides and Like 
Sex Four 2 (LSF2) glucan phosphatase polypeptides having 
20 
',,
0 
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(2) at least one amino acid mutation. Embodiments of the pres- 25 
ently-disclosed subject matter also relate to methods of uti-
lizing glucan phophatase polypeptide variants to alter starch 
metabolism and structure. 
INTRODUCTION 
eo H"'~o rHO r O 1 PH O ~0~ 
Starch plays a central role in many aspects of daily life: it 
is a major food source, it is key to biofuels, and it is an 
industrial feedstock, and increasing demand for starch has led 
to competition for it among these industries. Starch from the 35 
seeds of cereal crops and the tubers of potatoes and cassava 
accounts for 50-80% of daily caloric intake (Copeland 
(2009), Keeling (2010)). In the U.S., >20% of com starch is 
converted into ethanol for use as a renewable biofuel, and 
starch also plays a central role in the production of molecular 40 
hydrogen by some micro algae and in algal oil production (see 
e.g. USDA (2010)). Microalgal oil production is increased by 
supplying starch to the microalgae so that they grow mix-
otrophically (i.e. utilizing carbon from starch and photosyn-
thesis) rather than autotrophically (Malcata (2011), Bhatna- 45 
gar (2011), Chen (2011)). Starch is also a cheap and 
renewable industrial feedstock for producing paper, textiles, 
adhesives, plastics, and pharmaceuticals (Delcour (2011 ), 
Santelia (2011)). 
Given the high demand for starch, there has been a demand 50 
for developing "designer starches" that possess novel bio-
physical properties and functionalities to improve nutrition, 
increase energy supplies, and provide safer and cheaper 
industrial feedstocks (Santelia (2011, Jobling (2004), Morell 
(2005)). However, known chemicals that modifY the bio- 55 
physical properties of native starch for industrial applications 
are hazardous (Jobling (2004), Morell (2005), Tester (2000), 
Tharanathan (2005)). On the other hand, starch phosphoryla-
tion remains the only known natural starch modification and 
can affect many of starch's biophysical properties, including 60 
viscosity, paste stickiness, and starch granule fragility (San-
telia (2011), Jobling (2004), Blennow (2003), Blennow 
(2000)). 
Starch is comprised of the glucose polymer amylose, 
which is a linear molecule comprised of glucose moieties 65 
linked together by a-1 ,4-glycosidic bonds with very few 
branches, and amylopectin, which is comprised of glucose 
OH OH 
Starch degradation via hydrolysis is catalyzed by isoamy-
lase, a-amylase, and ~-amylases (BAMs) and involves 
reversible starch phosphorylation and dephosphorylation 
(34-37). Starch is phosphorylated by glucan water dikinase 
(GWD), which phosphorylates the C6 position of glucose 
moieties and triggers C3 phosphorylation by phosphoglucan 
water dikinase (PWD) (Ritte (2006), Ritte (2002) Kotting 
(2005), Baunsgaard (2005)). Without being bound by theory 
or mechanism, it is believed that C3 phosphorylation imposes 
steric effects inducing a conformational change in the outer 
glucans of starch making them water-soluble and accessible 
to BAMs and isoamylase (Hansen (2008), Hansen (2009), 
Kozlov (2007), Sanderson (2006)). However, glucan phos-
phatase activity is required for BAMs to completely degrade 
the glucan chains (Kotting (2009)). 
Glucan phosphatases are members of the protein tyrosine 
phosphatase (PTP) superfamily characterized by a conserved 
Cx5R catalytic motif (Yuvaniyama (1996), Gentry (2007)). 
The PTPs include a heterogeneous group of phosphatases 
called the Dual Specificity Phosphatases (DSPs) that dephos-
phorylate phospho-Ser, -Thr, and -Tyr of proteinaceous sub-
strates as well as more diverse substrates such as lipids, 
nucleic acids, and glucans (Alonso (2003), Tonks (2006), 
Moorhead (2009)). 
Starch EXcess 4 (SEX4) is one type of glucan phosphatase. 
SEX4 contains a chloroplast Targeting Peptide ( cTP), a Dual 
Specificity Phosphate (DSP) domain, a Carbohydrate Bind-
ing Molecule (CBM), and a carboxy-terminal (CT) domain 
that cradles the DSP and CBM. SEX4 works in synergy with 
glucan hydrolases to catabolize starch (Kotting (2009)). 
While the role of SEX4 in starch metabolism is still being 
defined, deletion ofSEX4 results in excess starch and a severe 
decrease in total biomass (Santelia (2011 ), Kotting (2009), 
Niittyla (2006)). Manipulation of this system holds intriguing 
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promise with respect to increasing starch yields, but will 
require engineering rather than gene deletion. 
An additional concern is that starch processing requires 
hazardous chemicals in order to modify it for industrial appli-
cation. Starch-based feedstocks are generated by an approach 5 
utilizing harsh chemical (acid and base treatment) and physi-
cal (> 100° C.) extremes combined with large quantities of 
amylase enzymes to degrade or modify native starch for 
industrial applications. Innovative strategies are needed to 
both increase starch production and to provide safer and 10 
cheaper starch-based feedstocks. Thus, there remains a need 
for a natural starch modification that can alter starch metabo-
lism without the use of hazardous chemicals. Glucan phos-
phatases are one area of interest, since they generally function 
to catabolize starch. However, deletion of glucan phos- 15 
phatases, such as SEX4, results in excess starch synthesis and 
starch biomass reduction so that overall starch production is 
not efficiency increased. Hence, glucan phosphatase 
polypeptide variants that produce "designer starches" pos-
sessing novel biophysical properties and altered starch biom- 20 
ass are highly desired. 
4 
Moss (201 0) ). While LSF 1 is required for starch degradation, 
it lacks phosphatase activity and is not considered a glucan 
phosphatase (Comparot-Moss (2010)). Conversely, LSF2 
binds and dephosphorylates glucans, but it is notable that this 
glucan phosphatase lacks a CBM (Santelia (2011)). Indeed, 
the glucan phosphatase family was first defined as any protein 
containing both a DSP and CBM (Gentry (2007)). Thus, the 
physical basis for LSF2-starch interaction and dephosphory-
lation is unclear, although it has been previously suggested 
that LSF2 may use a scaffold protein or an unidentified glu-
can-binding interface to maintain interactions with starch 
(Comparot-Moss (2010, Santelia 2011)). 
SUMMARY 
The presently-disclosed subject matter meets some or all of 
the above-identified needs, as will become evident to those of 
ordinary skill in the art after a study of information provided 
in this document. 
This Summary describes several embodiments of the pres-
ently-disclosed subject matter, and in many cases lists varia-
tions and permutations of these embodiments. This Summary 
is merely exemplary of the numerous and varied embodi-
ments. Mention of one or more representative features of a 
given embodiment is likewise exemplary. Such an embodi-
ment can typically exist with or without the feature(s) men-
tioned; likewise, those features can be applied to other 
embodiments of the presently-disclosed subject matter, 
whether listed in this Summary or not. To avoid excessive 
30 repetition, this Summary does not list or suggest all possible 
combinations of such features. 
The glucan phosphatase Starch EXcess 4 (SEX4) has been 
shown to preferentially dephosphorylate the C6-position and 
Like Sex Four 2 (LSF2) specifically dephosphorylates the 
C3-position of glucose moieties (Hejazi (2010), Santelia 25 
(2011)). However, the structural basis for specific glucan 
phosphatase activity and position specificity has not been 
determined. LSF2 and SEX4 are DSPs that are conserved in 
Archaeplastida/Plantae genomes from land plants to single-
cell green algae (Gentry (2007), Gentry and Pace (2009), 
Santelia (2011 )). Arabi do psis lacking SEX4 activity have 
larger starch granules, higher level of leaf starch, and altered 
patterns of starch phosphorylation, a phenotype further exac-
erbated upon the simultaneous loss ofLSF2 activity (Zeeman 
(2002), Niittyla (2006), Kotting (2009), Santelia (2011)). 
Furthermore, LSF2 and SEX4 are functional homologs to the 
glycogen phosphatase laforin that is found in all vertebrates 
and a subset of unicellular protozoa (Worby (2006), Gentry 
(2007), Tagliabracci (2007), Gentry (2009)). Mutations in the 
gene that encodes laforin in humans cause the accumulation 
of insoluble carbohydrates leading to the fatal epileptic dis-
order Lafora's disease (Minassian (1998), Serratosa (1999), 
Gentry (2009) ). These findings demonstrate that glue an phos-
phatase activity is highly conserved in nature and essential for 
both starch and glycogen metabolism. SEX4 and LSF2 pro-
teins both contain a chloroplast Targeting Peptide (cTP), a 
DSP domain, and a unique C-Terminal (CT) motif (Niittyla 
(2006), Sokolov (2006), Gentry (2007), Kotting (2009), 
VanderKooi (201 0), Santelia (2011 )). 
Chloroplast targeting pep tides localize proteins to the chlo-
roplast, the site of starch metabolism. The CT motif was 
originally identified in the SEX4 structure as a motif that folds 
into the DSP core and is essential for protein stability and 
function (VanderKooi (2010)). Additionally, SEX4 contains 
The presently-disclosed subject matter includes glucan 
phosphatase polypeptide variants. In some embodiments the 
glucan phosphatase polypeptide variant is a Starch EXcess 4 
35 (SEX4) glue an phosphatase polypeptide variant or a Like Sex 
Four2 (LSF2) glucan phosphatase polypeptide variant. In 
some embodiments the glucan phosphatase polypeptide vari-
ant comprises an amino acid mutation in the Dual Specificity 
Phosphatase (DSP) domain of the glucan phosphatase 
40 polypeptide variant. The presently-disclosed subject matter 
further includes nucleotides sequences, including isolated 
eDNA molecules, that encode glucan phosphatases polypep-
tide as disclosed herein. 
In some embodiments the glucan phosphatase polypeptide 
45 variants comprise a wild type amino acid sequence corre-
sponding to SEQ ID NO: 1 comprising a mutation or combi-
nation of mutations selected from the group consisting of 
Y139A, F167A, M204A, F235A, K237R, K237N, K237S, 
W278A, K307A, W314A, N326A, D328A, N332A, T201K, 
50 T201S, A202T, M204T, M204A, M204R, M204L, G205D, 
G205S, F235G, Y139A/F167A, W278A/W314A, W278A/ 
F167A, N326A/N332A, N332A/K307A, A202T/G205D, 
F235G/K237N, Y139A/F167A/F235A, W278A/W314A/ 
F167A, and N326A/N332A/K307A. 
In some embodiments, the glue an phosphatase polypeptide 
variant can additionally include up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11, 12,13, 14, 15, 16, 17,18, 19,20,21,22,23,24,25,26,27, 
28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44, 
45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, or 57 additional 
a Carbohydrate Binding Module (CBM) that is common in 55 
starch-interacting enzymes, while LSF2 lacks a CBM (Niit-
tyla (2006), Sokolov (2006), Gentry (2007)). CBMs are non-
enzymatic domains that typically bind a specific carbohy-
drate and allow the catalytic portion of the enzyme to modify 
the substrate (Coutinho and Henrissat (1999), Boraston 
(2004), Machovic and Janecek (2006)). The previously deter-
mined glucan-free SEX4 structure (PDB: 3NME) demon-
strated that its CBM and DSP domains interact to form a 
continuous binding pocket that coordinates the dual functions 
60 amino acid substitutions relative to SEQ ID NO: 1. In some 
embodiments, the additional amino acid substitutions are 
conservative amino acid substitutions. In some embodiments, 
the additional amino acid substitutions do not substantially 
alter function of the polypeptide. In some embodiments, the 
of glucan binding and dephosphorylation (Vander Kooi 
(2010)). An additional plant protein called Like Sex Four 1 
(LSFl) also contains a CBM and DSP domain (Comparot-
65 additional amino acid substitutions are not located in a Dual 
Specificity Phosphatase (DSP) domain of the glucan phos-
phatase polypeptide. 
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264,265,266,267,268,269,270,271,272,273,274,275, 
276, 277, 278, 279, 280, or 281 amino acids long. 
In some embodiments, the glucan phosphatase polypeptide 
variant can comprise a wild type amino acid sequence corre-
sponding to a fragment of SEQ ID NO: 1 comprising a muta-
tion or combination of mutations selected from the group 
consisting of Y139A, F167A, M204A, F235A, K237R, 
K237N, K237S, W278A, K307A, W314A, N326A, D328A, 
N332A, T201K, T201S, A202T, M204T, M204A, M204R, 
M204L, G205D, G205S, F235G, Y139A/F167A, W278A/ 
W314A, W278A/F167A, N326A/N332A, N332A/K307A, 
A202T/G205D, F235G/K237N, Y139A/F167A/F235A, 
W278A/W314A/F167A, and N326A/N332A/K307A. The 
fragment of SEQ ID NO: 1 can include up to about 1, 2, 3, 4, 
The presently-disclosed subject matter further includes a 
composition comprising starch, wherein the starch is from a 
5 plant expressing a glucan phosphatase polypeptide having an 
amino acid mutation (glucan phosphatase polypeptide vari-
ant). 
The presently-disclosed subject matter further includes a 
method of producing starch, which comprises providing a 
5, 6, 7, 8, 9, or 10 amino acid deletions from theN-terminus 
or up to about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 
10 plant that comprises a glucan phosphatase polypeptide vari-
ant and collecting starch from the plant. In some embodi-
ments the glucan phosphatase variant can alter the biophysi-
cal properties and/or the total biomass of the starch that is 
collected. In some embodiments the glucan phosphatase vari-
15 ant has more or less specific glucan phosphatase activity than 
a wild type glucan phosphatase. In some embodiments, plants 
that comprise the glucan phosphatase variant produce more 
starch biomass than plants having the wild type glucan phos-
17, 18, 19, or 20 amino acid deletions from the C-terminus. 
Fragments are typically at least about 340, 341, 342, 343, 344, 
345,346,347,348,349,350,351,352,353,354,355,356, 
357,358,359,360,361,362,363,364,365,366,367,368, 
369, 370, 371, 372, 373, 374, 375, 376, 377, or 378 amino 20 
acids long. 
phatase. 
BRIEF DESCRIPTION OF THE SEQUENCE 
LISTING 
SEQ ID NO: 1 is an amino acid sequence encoding a wild 
type Arabidopsis Starch Excess 4 (SEX4) glucan phosphate 
polypeptide; 
SEQ ID NO: 2 is an amino acid sequence encoding a wild 
type Arabidopsis Like Sex Four2 (LSF2) glucan phosphate 
polypeptide; 
SEQ ID NO: 3 is an truncated portion of the polypeptide of 
SEQ ID NO: 1 that includes four additional terminal amino 
acids and that was subjected to crystallization; and 
In some embodiments the glucan phosphatase polypeptide 
variants comprise a wild type amino acid sequence corre-
sponding to SEQ ID NO: 2 comprising a mutation or combi-
nation of mutations selected from the group consisting of 25 
S194A, S194K, S194T, S194N, S194Q, A195G, A195M, 
A195D, A195H, A195E, L197M, Q129A, D130A, K131A, 
D163A, D161A, D132A, K160A, G198A, G230A, K233A, 
N232A, Y135A, Y85A, Y83A, W136A, W136A/F162A, 
W136M, F162Y, F162M, F162A, F162T, F162N, R153A, 30 
M155A, R156A, R157A, S177A, S177R, S177Q, S177Y, 
W180A, W180A/F261A, LSF2-C-terminalRGT, K250A, 
E251A, N159A, F261A, D263A, W267A, E268A, LSF2+ 
sex4CBM, G230F, G230F/N232K, N232K, G230Y, G230Y/ 
N232D, N232D, W136F, W136N, and K245A. 
SEQ ID NO: 4 is an truncated portion of the polypeptide of 
SEQ ID NO: 2 that includes four additional terminal amino 
35 acids and that was subjected to crystallization. 
In some embodiments, the glucan phosphatase polypeptide 
variantcanadditionallyincludeup to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11,12,13, 14, 15, 16, 17,18, 19,20,21,22,23,24,25,26,27, 
28,29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, or42 
additional amino acid substitutions relative to SEQ ID NO: 2. 40 
In some embodiments, the additional amino acid substitu-
tions are conservative amino acid substitutions. In some 
embodiments, the additional amino acid substitutions do not 
substantially alter function of the polypeptide. In some 
embodiments, the additional amino acid substitutions are not 45 
located in a Dual Specificity Phosphatase (DSP) domain of 
the glucan phosphatase polypeptide. 
In some embodiments, the glucan phosphatase polypeptide 
variant can comprise a wild type amino acid sequence corre-
sponding to a fragment of SEQ ID NO: 2 comprising a muta- 50 
tion or combination of mutations selected from the group 
consisting of S194A, S194K, S194T, S194N, S194Q, 
A195G, A195M, A195D, A195H, A195E, L197M, Q129A, 
D130A, K131A, D163A, D161A, D132A, K160A, G198A, 
G230A, K233A, N232A, Y135A, Y85A, Y83A, W136A, 55 
W136A/F162A, W136M, F162Y, F162M, F162A, F162T, 
F162N, R153A, M155A, R156A, R157A, S177A, S177R, 
S177Q, S177Y, W180A, W180A/F261A, LSF2-C-terminal-
RGT, K250A, E251A, N159A, F261A, D263A, W267A, 
E268A, LSF2+sex4CBM, G230F, G230F/N232K, N232K, 60 
G230Y, G230Y/N232D, N232D, W136F, W136N, and 
K245A. The fragment of SEQ ID NO: 2 can include up to 
about 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acid deletions from 
theN-terminus or up to about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 
13, 14, 15, 16, 17, 18, 19,or20aminoaciddeletionsfromthe 65 
C-terminus. Fragments are typically at least about 250, 251, 
252,253,254,255,256,257,258,259,260,261,262,263, 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a crystal structure of Arabidopsis LSF2 with 
bound maltohextaose (PDB: 4KYR). 
FIG. 2 is a crystal structure of Arabidopsis LSF2 without 
bound maltohextaose (PDB: 4KYQ). 
FIG. 3A shows the SEX4 domains. 
FIG. 3B depicts the integrated architecture ofDSP (pink), 
CBM (green), and C-terminal (blue) domains. 
FIG. 3C depicts a ribbon diagram of SEX4 (residues 
90-379), in which elements of secondary structure are num-
bered consecutively from N- to C-termini (PDB: 3NME). 
FIG. 4 shows the domains of laforin, SEX4, and LSF2 
glucan phosphatases, wherein the catalytic site motif is 
shown above each DSP, in accordance with the present inven-
tion. 
FIG. SA is a graph showing release of phosphate from 
phospho-glucans by different phosphatases. 
FIG. SB shows laforin targeted to the chloroplast via a 
chloroplast targeting peptide (cTP) replaces SEX4 inArabi-
dopsis. 
FIG. SC shows starch content/fresh weight (FW) in WT 
and sex4-/- plants. 
FIG. SD shows plant biomass in WT and sex4-/- plants. 
FIG. SE shows results of a glucan binding assay (proteins 
bound to glucans (P); proteins not bound to glucan (S). 
FIG. 6 is a graph showing release of phosphate from starch 
at C6 or C3 by SEX4, laforin, and LSF2, in accordance with 
the present invention. 
FIG. 7 A-7E relate to the structural dynamics of SEX4. 
FIG. 7A shows DXMS results ofligand-free SEX4. 
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FIG. 7B shows percent change in deuteration ofligand-free 
vs. glucan bound. 
FIG. 7C shows SEX4 structure overlaid with DXMS 
results. 
FIG. 7D shows 180° rotation ofSEX4 structure with over- 5 
lay. 
FIG. 7E shows models of SEX4 dynamics upon glucan 
binding (white star indicates the position of the active site). 
8 
active site. (C) 2Fo-Fc (a 1.1) and (D) Fo-Fc (a 2.5) density 
maps ofmaltohexaose (cyan) at Site-2. (E) 2Fo-Fc (a 1.1) and 
(F) Fo-Fc (a 2.5) density maps of maltohexaose chains Hex-1 
(orange) and Hex-2 (pink) at Site-3. 
FIGS. 13A and 13B relate to the LSF2 aromatic Channel 
wherein FIG. 13A shows a maltohexaose chain (green) inter-
acts with aromatic channel residues at the LSF2 active site. 
Y83 and Y85 are located in the recognition domain amino-
terminal fromal.Yl35 and Wl36 are located in the V-loop in FIG. SA shows Chimera constructs ofGP domains. 
FIG. SB shows expression of SEX4-llCBM. 
FIG. SC shows an expression of LSF2+CBM (UI-unin-
duced; !-induced; P-pellet/insoluble; S-soluble; E---elu-
tion). 
10 a3. Fl62 is located in the D-loop between ~4 and a5. The 
total contact area of the aromatic channel residues with mal-
tohexaose is 266 A2 . FIG.13B depicts the specific activity of 
aromatic channel mutants against the C3-position of Arabi-
FIG. SD shows LSF2+CBM and LSF2 glucan binding. 
FIG. 9A-9E shows the structure of LSF2 bound to mal to- 15 
hexaose and phosphate, wherein FIG. 9A is a ribbon diagram 
of LSF2 (residues 79-282). Maltohexaose chains (green, 
cyan, orange, pink) and phosphate (teal) are shown. Elements 
of secondary structure are numbered consecutively from N-
dopsis starch granules. Phosphate-free starch from gwd-de-
ficient plants (Yu (2001)) was purified and pre-labeled at the 
C3- or C6-position with 33P as in FIG. 13C. The labeled 
starch was then incubated with LSF2 WT or LSF2 aromatic 
channel mutants and starch dephosphorylation was measured 
via release o[33 P. The reaction time was 5 minutes. Each bar 
is the mean± standard deviation of 6 replicates. Mutated resi-
dues are marked with an asterisk in FIG. 20. FIG.13C shows 
a substrate-dependent positional rearrangement of the 
D-loop. D-loop residues Fl62 (aromatic channel) and Dl61 
(catalytic residue) lie between P4 and a5 and undergo sig-
to C-termini. FIG. 9B shows a maltohexaose chain (green) 20 
and phosphate (teal) at the active site (red) channel. Image 
correlates with the red box in FIG. 9A. Glucose moieties are 
numbered from non-reducing to reducing end. The total con-
tact area of the active site channel with phosphate and mal-
tohexaose is 511 A2 . FIG. 9C is a graph showing specific 
activity ofLSF2 WT and inactive mutant LSF2 Cl93S (CIS) 
against the C6- and C3-position of Arabi do psis starch. Phos-
phate-free starch was purified from gwd-deficientArabidop-
25 nificant movement in the maltohexaose/phosphate bound 
(blue/yellow) versus the unbound (gray/blue) LSF2 struc-
sis (Yu (2001)) the starch was pre-labeled with 33P at either 
the C6- or C3-position, and then incubated with recombinant 30 
protein. Starch dephosphorylation over time was linear and 
was measured via release of 33P. The reaction time was 5 
minutes. Each bar is the mean±standard deviation of 6 repli-
cates. FIG. 9D is a 2Fo-Fc omit density map ofmaltohexaose 
chain (green) and phosphate (teal) at the active site (a 1.35). 35 
The 03 group ofGlc3 is highlighted. FIG. 9E is a LSF2 active 
site catalytic triad (yellow) residues interact with malto-
hexaose and phosphate. S(C)193 (catalytically inactive 
mutant, Cl93S) and Rl99 are located within the PTP loop 
between ~5 and a6 and Dl61 is located within the D-loop 40 
between ~4 and a5. 
FIG.10 relates to DSP subdomains in LSF2. Multiple DSP 
subdomains converge to interact with the maltohexaose chain 
(green) at the LSF2 active site. DSP subdomains are colored 
as follows: recognition domain (brown), V-loop (variable 45 
loop, pink), D-loop (WPD-loop, orange), PTP-loop (red), and 
R-motif (blue). The recognition domain consists of residues 
83-92 and is locatedonandamino-terminal to al. The V-loop 
consists of residues 132-150 and contains a3 and a4. The 
D-loop consists of residues 158-163 and is located between 50 
~4 and a5. The PTP-loop consists of residues 192-199 and is 
located between ~5 and a6. The R-motif consists of residues 
225-249 and contains part of a7 and all of aS. 
FIG. 11 relates to conservation of LSF2 orthologs and 
Sequence conservation from 21 genomes containing LSF2 55 
from Kingdom Plantae/ Archaeplastida. Primary sequence 
alignment was produced using ClustalW and Arabidopsis 
thaliana LSF2 residues 79-282. The chloroplast-Targeting 
Peptide ( cTP) was highly variable between organisms, thus it 
was excluded for clarity. Secondary structure from the LSF2 60 
structure is shown above. DSP subdomains are depicted and 
colored according to Supplemental FIG. 1. Residues involved 
in glucan binding in the active site aromatic channel (aster-
isk), Site-2 (circle) and Site-3 (triangle) are highlighted. 
FIG. 12 relates to electron density maps ofligands in LSF2 65 
structure. (A) 2Fo-Fc (a 1.1) and (B) Fo-Fc (a 2.5) density 
maps of maltohexaose (green) and phosphate (teal) at the 
tures. 
FIG. 14 shows Specific activity of LSF2 and mutants 
against para-nitrophenyl phosphate (pNPP) pNPP dephos-
phorylation over time was linear and measured via colorimet-
ric change at 410 nm. Reaction time was 5 minutes. Each bar 
is the mean±standard deviation of 6 replicates. (A) pNPP 
activity of aromatic channel mutants. (B) pNPP activity of 
Site-2 mutants. (C) pNPP activity of Site-3 mutants, includ-
ing combinatorial Site-2, Site-3 and aromatic channel 
mutants. 
FIG. 15 shows a stereo view of citrate at the LSF2 active 
site. Ribbon structure of LSF2 with citrate (green) at the 
active site to aresolutionof1.65 A withFo-Fc omit density (a 
3.0) map of citrate at the active site. 
FIG.16 shows a Structural alignment ofDSP catalytic triad 
of LSF2 Structural alignment with the catalytic triad of the 
DSPs SEX4 (3NME), VHR (1 VHR), and Slingshot-2 (SSH2, 
2NT2). LSF2 residues D161, Rl99, and Sl93 (catalytically 
inactive mutant Cl93S) are labeled. (A) Structural alignment 
ofLSF2 (blue) and SEX4 (green). (B) Structural alignment of 
LSF2 (blue) and VHR (cyan). (C) Structural alignment of 
LSF2 (blue) and SSH2 (dark blue). 
FIGS. 17 A and 18B show LSF2 glucan binding sites. FIG. 
17 A shows results from co-sedimentation assay of protein 
and amylopectin (amylopectin binding assay). Recombinant 
histidine-tagged proteins were incubated with 5 mg/ml amy-
lopectin, amylopectin was pelleted by ultracentrifugation, 
proteins in the pellet (P) and supernatant (S) were separated 
by SDS-PAGE, and visualized by Western analysis. Amy-
lopectin-bound proteins are found in the pellet (P) and 
unbound proteins are found in the supernatant (S). FIG. 17B 
is a surface model of LSF2 showing DSP domain (blue) and 
CT motif (green). Maltohexaose chains at the active site 
(green), Site-2 (cyan), and Site-3 (orange, pink) are shown. 
FIG.18A-19C show LSF2 glucan binding Site-2, wherein 
FIG. 18A is a transparent surface model of LSF2 Site-2 
showing DSP domain (blue) and CT-motif (green) interaction 
with the maltohexaose chain (cyan). Rl53 and Ml55 are 
located on ~4. Rl57 is located between ~4 and a5. Wl80 is 
located on a5. T282 is located on the carboxy-terminus after 
all. Glucose moieties are numbered from non-reducing to 
US 9,410,133 Bl 
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reducing end. The total contact area of Site-2 with malto-
hexaose is 391 A2 . FIG. 18B shows specific activity ofSite-2 
mutants against the C3-position of Arabidopsis starch gran-
ules. Phosphate-free starch from gwd-deficient plants (Yu 
(200 1)) was purified and pre-labeled at the C3- or C6-position 5 
with 33P as in FIG. 13B. The labeled starch was then incu-
bated with LSF2 WT or LSF2 Site-2 mutants and starch 
dephosphorylation was measured via release of 33P. In addi-
tion to single point mutants, starch dephosphorylation was 
also determined for LSF2lacking the carboxy-terminal resi- 10 
dues R280, G281, and T282 (llRGT). The reaction time was 
5 minutes. Each bar is the mean±standard error or standard 
deviation of 6 replicates. Mutated residues are marked with a 
circle in FIG. 20. 
FIG.18C is an amylopectin binding assay ofSite-2 mutant 15 
Rl57 A was performed in a similar manner as described in 
FIG. 17 A. LSF2 Rl57 A was co-sedimented with amylopec-
tin and found in the pellet (P) and supernatant (S). 
FIG.19A-20C show LSF2 glucan binding Site-3, wherein 
FIG. 19A is a transparent surface model of LSF2 at the 20 
CT-motif loop (green) showing specific interactions with 
maltohexaose chains Hex-1 (orange) and Hex-2 (pink). K245 
is located between aS and a9. F261 is located between alO 
and all. E268 is located in all. The total contact are of 
Site-3 with the maltohexaose chains is 338 A2 . FIG. 19B 25 
shows specific activity of Site-3 mutants against the C3-po-
sition of Arabidopsis starch granules. Phosphate-free starch 
from gwd-deficient plants (Yu (2001)) was purified and pre-
labeled at the C3- or C6-position with 33P as in FIG. 9C. The 
labeled starch was then incubated with LSF2 WT or LSF2 30 
Site-3 mutants and starch dephosphorylation was measured 
via release oe3 P. The reaction time was 5 minutes. Each bar 
10 
non-reducing ends due to phosphorylation. LSF2 interacts 
with starch via multiple binding sites: the LSF2 active site 
(highlighted in red) interacts with the C3-phosphorylated 
glucose moiety through coordination of the aromatic channel 
with six glucose units, Site-2 also interacts with six glucose 
moieties via hydrogen bonding and van der Waals contacts at 
an interface between the LSF2 DSP domain (blue) and the 
carboxy-terminal motif(CT, green), and Site-3 interacts with 
two helical-like glucan chains through interactions with the 
CTmotif. 
DESCRIPTION OF EXEMPLARY 
EMBODIMENTS 
The details of one or more embodiments of the presently-
disclosed subject matter are set forth in this docnment. Modi-
fications to embodiments described in this document, and 
other embodiments, will be evident to those of ordinary skill 
in the art after a study of the information provided in this 
document. The information provided in this docnment, and 
particularly the specific details of the described exemplary 
embodiments, is provided primarily for clearness of under-
standing and no unnecessary limitations are to be understood 
therefrom. In case of conflict, the specification of this docu-
ment, including definitions, will control. 
The presently-disclosed subject matter includes glucan 
phosphatase polypeptide variants. The glucan phosphatase 
polypeptide variants disclosed herein can alter the biophysi-
cal properties of starch and/or total biomass starch produc-
tion. For example, some embodiments of glucan phosphatase 
polypeptide variants can increase total biomass starch pro-
duction in planta. The presently-disclosed subject matter fur-
ther relates to a composition comprising starch, wherein the 
starch is from a plant expressing a glucan phosphatase variant 
having an amino acid mutation. Still further, the presently-
disclosed subject matter includes a method of producing 
starch, which comprises providing a plant that comprises a 
glucan phosphatase polypeptide variant, as disclosed herein 
is the mean±standard deviation of 6 replicates. Mutated resi-
dues are marked with a triangle in FIG. 20. FIG. 19C is an 
amylopectin binding assay of Site-3 mutant F261A, Site-2/ 35 
Site-3 mutant (R157A/F261A) and quadruple mutation of 
active site, Site-2 and Site-3 (F162A/Wl36A/Rl57A/ 
F261A) was performed in a similar manner as described in 
FIG. 17A. Amylopectin-bound protein is found in the pellet 
(P) and unbound protein is found in the supernatant (S). 
FIG. 20 relates to sequence conservation of LSF2 and 
SEX4. Arabidopsis thaliana-78-LSF2 sequence alignment 
with Arabidopsis thaliana-81-SEX4. Secondary structure 
ofLSF2 and SEX4 is depicted above the primary sequences 
(a-helices=ellipses, ~-sheets=boxes). DSP domain (blue), 45 
SEX4 CBM domain (orange), and CT motif (green) are 
labeled. Residues involved in LSF2 glucan binding are high-
lighted within the aromatic channel (asterisk), Site 2 (circle) 
and Site 3 (triangle). Residues in the aromatic channel are 
conserved between LSF2 and SEX4, however residues in Site 50 
40 comprising an amino acid mutation and collecting starch 
from the plant. Altering the biophysical properties or biomass 
production of starch can meet long felt but unmet needs that 
are being experienced in industries that use or produce starch. 
2 and Site 3 are not. 
FIG. 21 shows a proposed model of reversible phosphory-
lation at the starch granular surface during breakdown (modi-
fied from (Streb and Zeeman, 2013)). At night, starch is 
phosphorylated (red circles) by glucan dikinases, leading to 55 
solubilization of the outer starch granules via unwinding of 
amylopectin helices (gray bars). Amylopectin is then hydro-
lyzed by amylases into maltose and malto-oligosaccharides. 
However, these amylases cannot completely degrade phos-
In some embodiments, the glucan phosphatase polypeptide 
variant is a variant of a Starch Excess (SEX4) glucan phos-
phatase or a Like Sex Four2 (LSF2) glucan phosphatase. In 
some embodiments the glucan phosphatase polypeptide vari-
ant comprises a mutation, and the mutation can be in the DSP 
domain of the glucan phosphatase polypeptide variant. 
In still further embodiments the glucan phosphatase 
polypeptide variant is selected from a glucan phosphatase 
polypeptide variant set forth in Table 1. Table 1 includes the 
amino acid mutations for a wild type glucan phosphatase 
polypeptide that has the amino acid sequence associated with 
SEQ ID NO: 1. Embodiments of the presently-disclosed sub-
ject matter also comprise any combination and variation of 
mutations in Table 1. 
TABLE 1 
phorylated starch. Therefore, glucan phosphatases must 60 -----------------------
remove phosphate from partially degraded amylopectin Amino Acid Mutations Associated with SEQ ID N0:1 
chains. The outer starch surface is then fully degraded by 
amylases into malto-oligosaccharides, and the cycle is reset 
so that the next starch layer can be phosphorylated and 
degraded. The inset box illustrates a model of LSF2-glucan 
interaction. Amylopectin helices are comprised of two a-1, 
4-glycosidic linked chains that are partially unwound at their 
65 
Y139A 
F167A 
Single Mutant 
W278A T201S 
K307A A202T 
Double Mutant Triple Mutant 
G205S Y139A/F167A Y139A/F167A/ 
F235A 
F235G W278AIW314A W278A/W314A/ 
F167A 
US 9,410,133 Bl 
11 
TABLE !-continued 
Amino Acid Mutations Associated with SEQ ID N0:1 
Single Mutant Double Mutant Triple Mutant 
12 
K237N, K237S, W278A, K307A, W314A, N326A, D328A, 
N332A, T201K, T201S, A202T, M204T, M204A, M204R, 
M204L, G205D, G205S, F235G, Y139A/F167A, W278A/ 
W314A, W278A/F167A, N326A/N332A, N332A/K307A, 
M204A W314A M204T W278A/F167A N326A/N332A/ 
K307A 
5 A202T/G205D, F235G/K237N, Y139A/F167A/F235A, 
W278A/W314A/F167 A, and N326A/N332A/K307 A. 
F235A N326A 
K237R D328A 
K237N N332A 
M204A 
M204R 
M204L 
N326A/N332A 
N332A/K307A 
A202T/G205D 
In some embodiments, the glucan phosphatase polypeptide 
variant comprises the sequence of SEQ ID NO: 1 comprising 
K237S T201K G205D F235G/K237N 10 at least one amino acid mutations selected from the group 
consisting of Y139A, F167A, M204A, F235A, K237R, 
K237N, K237S, W278A, K307A, W314A, N326A, D328A, 
N332A, T201K, T201S, A202T, M204T, M204A, M204R, 
M204L, G205D, G205S, F235G, Y139A/F167A, W278A/ 
In some embodiments, the glucan phosphatase polypeptide 
variantcanadditionallyincludeup to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11,12,13, 14, 15, 16, 17,18, 19,20,21,22,23,24,25,26,27, 
28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44, 
45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, or 57 additional 
amino acid substitutions relative to SEQ ID NO: 1. In some 
embodiments, the additional amino acid substitutions are 
conservative amino acid substitutions. In some embodiments, 
the additional amino acid substitutions do not substantially 20 
alter function of the polypeptide. In some embodiments, the 
additional amino acid substitutions are not located in a Dual 
Specificity Phosphatase (DSP) domain of the glucan phos-
phatase polypeptide. 
15 W314A, W278A/F167A, N326A/N332A, N332A/K307A, 
A202T/G205D, F235G/K237N, Y139A/F167A/F235A, 
W278A/W314A/F167A, and N326A/N332A/K307A, and 
further comprising up to 10 conservative amino acid substi-
tutions. 
In some embodiments, the glucan phosphatase polypeptide 25 
variant can comprise a wild type amino acid sequence corre-
sponding to a fragment of SEQ ID NO: 1 comprising a muta-
In still further embodiments the glucan phosphatase 
polypeptide variant is selected from a glucan phosphatase 
polypeptide variant set forth in Table 2. Table 2 includes the 
amino acid mutations for a wild type glucan phosphatase 
polypeptide that has the amino acid sequence associated with 
SEQ ID NO: 2. Embodiments of the presently-disclosed sub-
ject matter also comprise any combination and variation of 
mutations in Table 2. 
LSF2 C/S 
S194A 
S194K 
S194T 
S194N 
S194Q 
A195G 
A195M 
A195D 
A195H 
tion or combination of mutations selected from the group 
consisting of Y139A, F167A, M204A, F235A, K237R, 
K237N, K237S, W278A, K307A, W314A, N326A, D328A, 
N332A, T201K, T201S, A202T, M204T, M204A, M204R, 
M204L, G205D, G205S, F235G, Y139A/F167A, W278A/ 
W314A, W278A/F167A, N326A/N332A, N332A/K307A, 
A202T/G205D, F235G/K237N, Y139A/F167A/F235A, 
W278A/W314A/F167A, and N326A/N332A/K307A. The 
fragment of SEQ ID NO: 1 can include up to about 1, 2, 3, 4, 
5, 6, 7, 8, 9, or 10 amino acid deletions from theN-terminus 
TABLE2 
Amino Acid Mutations Associated with SEQ ID NO: 2 
Single Mutant Double Mutant 
A195E G230A F162A S177Y LSF2 + sex4CBM W136A/F162A 
L197M K233A F162T W180A G230F W180A/F261A 
Q129A N232A F162N 1\.RGT N232K G230F/N232K 
D130A Y135A R153A K250A G230Y G230Y/N232D 
K131A Y85A M155A E251A N232D 
D163A Y83A R156A N159A W136F 
D161A W136A R157A F261A W136N 
D132A W136M S177A D263A K245A 
K160A F162Y S177R W267A 
G198A F162M S177Q E268A 
In some embodiments, the glucan phosphatase polypeptide 
45 variant can additionally include up to 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
11, 12,13, 14, 15, 16, 17,18, 19,20,21,22,23,24,25,26,27, 
28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, or42 
additional amino acid substitutions relative to SEQ ID NO: 2. 
50 
In some embodiments, the additional amino acid substitu-
or up to about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 55 
17, 18, 19, or 20 amino acid deletions from the C-terminus. 
Fragments are typically at least about 330, 331, 332, 333, 334, 
335,336,337,338,339,340,341,342,343,344,345,346, 
347,348,349,350,351,352,353,354,355,356,357,358, 
359,360,361,362,363,364,365,366,367,368,369,370, 60 
371, 372, 373, 374, 375, 376, 377, or 378 amino acids long. 
tions are conservative amino acid substitutions. In some 
embodiments, the additional amino acid substitutions do not 
substantially alter function of the polypeptide. In some 
embodiments, the additional amino acid substitutions are not 
located in a Dual Specificity Phosphatase (DSP) domain of 
the glucan phosphatase polypeptide. 
In some embodiments, the glucan phosphatase polypeptide 
variant can comprise a wild type amino acid sequence corre-
sponding to a fragment of SEQ ID NO: 2 comprising a muta-
tion or combination of mutations selected from the group 
consisting of S194A, S194K, S194T, S194N, S194Q, 
A195G, A195M, A195D, A195H, A195E, L197M, Q129A, 
D130A, K131A, D163A, D161A, D132A, K160A, G198A, 
G230A, K233A, N232A, Y135A, Y85A, Y83A, W136A, 
W136A/F162A, W136M, F162Y, F162M, F162A, F162T, 
F162N, R153A, M155A, R156A, R157A, S177A, S177R, 
S177Q, S177Y, W180A, W180A/F261A, LSF2-C-terminal-
In some embodiments, the glucan phosphatase polypeptide 
variant comprises a sequence having at least 85, 86, 87, 88, 
89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99% homology to a 
polypeptide having the sequence of SEQ ID NO: 1 compris- 65 
ing at least one amino acid mutations selected from the group 
consisting of Y139A, F167A, M204A, F235A, K237R, 
US 9,410,133 Bl 
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RGT, K250A, E251A, N159A, F261A, D263A, W267A, 
E268A, LSF2+sex4CBM, G230F, G230F/N232K, N232K, 
G230Y, G230Y/N232D, N232D, W136F, W136N, and 
K245A. The fragment of SEQ ID NO: 2 can include up to 
about 1, 2, 3, 4, 5, 6, 7, 8, 9, or 10 amino acid deletions from 5 
theN-terminus or up to about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 
13, 14, 15, 16, 17, 18, 19,or20aminoaciddeletionsfromthe 
C-terminus. Fragments are typically at least about 250, 251, 
252,253,254,255,256,257,258,259,260,261,262,263, 
264,265,266,267,268,269,270,271,272,273,274,275, 10 
276, 277, 278, 279, 280, or 281 amino acids long. 
In some embodiments, the glucan phosphatase polypeptide 
variant comprises a sequence having at least 85, 86, 87, 88, 
89, 90, 91, 92, 93, 94, 95, 96, 97, 98, or 99% homology to a 
polypeptide having the sequence of SEQ ID NO: 2 compris- 15 
ing at least one amino acid mutations selected from the group 
consisting of S194A, S194K, S194T, S194N, S194Q, 
A195G, A195M, A195D, A195H, A195E, L197M, Q129A, 
D130A, K131A, D163A, D161A, D132A, K160A, G198A, 
G230A, K233A, N232A, Y135A, Y85A, Y83A, W136A, 20 
W136A/F162A, W136M, F162Y, F162M, F162A, F162T, 
F162N, R153A, M155A, R156A, R157A, S177A, S177R, 
S177Q, S177Y, W180A, W180A/F261A, LSF2-C-terminal-
RGT, K250A, E251A, N159A, F261A, D263A, W267A, 
E268A, LSF2+sex4CBM, G230F, G230F/N232K, N232K, 25 
G230Y, G230Y/N232D, N232D, W136F, W136N and 
K245A. 
14 
function of the polypeptide. In this regard, the presently-
disclosed subject matter is inclusive of variants having the 
particular mutations disclosed herein that impact efficacy of 
the polypeptide for particular utilities, which variants can 
have one or more additional mutations that to not substan-
tially impact efficacy of the polypeptide for the particular 
utilities. For example, in some embodiments, conservative 
amino acid substitutions can be made without substantially 
impacting efficacy. Examples of conservative substitutions 
include the substitution of one non-polar (hydrophobic) resi-
due such as isoleucine, valine, leucine or methionine for 
another; the substitution of one polar (hydrophilic) residue 
for another such as between arginine and lysine, between 
glutamine and asparagine, between glycine and serine; the 
substitution of one basic residue such as lysine, arginine or 
histidine for another; or the substitution of one acidic residue, 
such as aspartic acid or glutamic acid for another. In some 
embodiments, a variant can have 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 
12, 13,14, 15, 16, 17, 18,19,20,21,22,23,24,25,26,27,28, 
29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45, 
46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, or 57 additional 
mutations that are conservative substitutions. 
The terms "polypeptide fragment" or "fragment", when 
used in reference to a reference polypeptide, refers to a 
polypeptide in which amino acid residues are deleted as com-
pared to the reference polypeptide itself, but where the 
remaining amino acid sequence is usually identical to the 
corresponding positions in the reference polypeptide. Such 
deletions can occur at the amino-terminus, carboxy-terminus 
I some embodiments, the glucan phosphatase polypeptide 
variant comprises the sequence of SEQ ID NO: 2 comprising 
at least one amino acid mutations selected from the group 
consisting of S194A, S194K, S194T, S194N, S194Q, 
A195G, A195M, A195D, A195H, A195E, L197M, Q129A, 
D130A, K131A, D163A, D161A, D132A, K160A, G198A, 
G230A, K233A, N232A, Y135A, Y85A, Y83A, W136A, 
W136A/F162A, W136M, F162Y, F162M, F162A, F162T, 
F162N, R153A, M155A, R156A, R157A, S177A, S177R, 
S177Q, S177Y, W180A, W180A/F261A, LSF2-C-terminal-
RGT, K250A, E251A, N159A, F261A, D263A, W267A, 
E268A, LSF2+sex4CBM, G230F, G230F/N232K, N232K, 
G230Y, G230Y/N232D, N232D, W136F, W136N and 
K245A, and further comprising up to 10 conservative amino 
acid substitutions. 
30 of the reference polypeptide, or alternatively both. A frag-
ment can also be a "functional fragment," in which case the 
fragment retains some or all of the activity of the reference 
polypeptide as described herein 
As used herein, the terms "polypeptide", "protein", and 
"peptide", which are used interchangeably herein, refer to a 
polymer of the protein amino acids, or amino acid analogs, 
regardless of its size or function. Although "protein" is often 
used in reference to relatively large polypeptides, and "pep-
tide" is often used in reference to small polypeptides, usage of 
these terms in the art overlaps and varies. The term "polypep-
tide" as used herein refers to peptides, polypeptides, and 
proteins, unless otherwise noted. The terms "protein", 
"polypeptide", and "peptide" are used interchangeably herein 
when referring to a gene product. Thus, exemplary polypep-
tides include gene products, naturally occurring proteins, 
homologs, orthologs, paralogs, fragments and other equiva-
lents, variants, and analogs of the foregoing. 
"Percent identity," or "percent homology" when used 
35 herein to describe to an amino acid sequence or a nucleic acid 
sequence, relative to a reference sequence, can be determined 
using the formula described by Karlin and Altschul (Proc. 
Nat!. Acad. Sci. USA 87: 2264-2268, 1990, modified as in 
Proc. Nat!. Acad. Sci. USA 90:5873-5877, 1993). Such a 
40 formula is incorporated into the basic local alignment search 
tool (BLAST) programs of Altschul eta!. (J. Mol. Bioi. 215: 
403-410, 1990). [BLAST nucleotide searches are performed 
with the NBLAST program, score+lOO, wordlength=12, to 
obtain nucleotide sequences homologous to a nucleic acid 
45 molecule of the invention. BLAST protein searches are per-
formed with the XBLAST program, score=50, word 
length=3, to obtain amino acid sequences homologous to a 
reference polypeptide (e.g., SEQ ID NO: X). To obtain 
gapped alignments for comparison purposes, Gapped 
50 BLAST is utilized as described in Altschul, et a!. (Nucleic 
Acids Res. 25: 3389-3402, 1997). When utilizing BLAST 
and Gapped BLAST programs, the default parameters of the 
respective programs (e.g., XBLAST and NBLAST) are used. 
See http://www.ncbi.nlm.nik.gov, and reference is made to 
55 the most recent version of the programs that are available as of 
Jul. 19, 2012. 
Glucan phosphatases dephosphorylate glucans in starch in 
starch metabolism. In some instances, glucan phosphatases 
dephosphorylate glucans so that starch can be completely 
60 degraded by ~-amylase. Thus, mutations in the amino acid 
sequences of glucan phosphatase polypeptide variants can 
affect the metabolism of starch. 
The term "variant" refers to an amino acid sequence that is 
different from the reference polypeptide by one or more 
amino acids, e.g., one or more amino acid substitutions. For 
example a glucan phosphate polypeptide variant differs from 
wild-type glucan phosphatase by one or more amino acid 
substitutions, i.e., mutations. In this regard, polypeptide vari-
ants comprising combinations of two or more mutations can 
respectively be referred to as double mutants, triple mutants, 
and so forth. It will be recognized that certain mutations can 65 
result in a notable change in function of a polypeptide, while 
other mutations will result in little to no notable change in 
Some embodiments comprise a composition including 
starch that is from a plant expressing a glucan phosphatase 
variant having an amino acid mutation. As discussed above, 
plants expressing a glucan phosphatase polypeptide variant 
can produce starch with altered biophysical properties, which 
US 9,410,133 Bl 
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can be beneficial for manufacturing processes in various 
industries, including food, beverage, confectionary, plastic, 
paper, building, energy, textile, agriculture, and pharmaceu-
tical industries. Plants expressing embodiments of glucan 
phosphatase polypeptide variants can also exhibit increased 5 
starch biomass production relative to plants expressing wild 
type glucan phosphatases, and increased starch biomass can 
be useful in biofuel industries, for example. 
this assay utilizes an endogenous substrate, one can only 
determine a specific activity and cannot obtain kinetic param-
eters due to the heterogeneity of the substrate, i.e. phosphate 
within amylopectin. 
Lastly, an endogenous substrate was utilized to measure 
the position phosphate is released off of glucose and kinetic 
parameters (Santelia (2001 ), Kotting (2009)). Starch was iso-
lated from plants lacking the two dikinases ( G WD and PWD ), 
so that the starch contained very little to no phosphate, and 
used the sample was dialyzed to remove free phosphate. The 
C6 position was radio-labeled by adding GWD in the pres-
Some embodiments include a method of producing starch, 
which comprises providing a plant that comprises a glucan 10 
phosphatase polypeptide variant, as disclosed herein, com-
prising an amino acid mutation and collecting starch from the 
plant. The term "plant" is used herein to refer to any plant that 
can produce starch for collection. 
ence oe3P-~-ATP ( dikinases transfer the ~-phosphate), dia-
lyzing and precipitating out the 33P-~-ATP and GWD, adding 
non-radio-labeledATP with PWD, dialyzing and precipitate 
out the ATP and PWD, and utilizing this starch as the sub-
strate. The C3 position was radio-labeled by adding 33P-~­
ATP with PWD instead of with GWD. 
In this regard, the term "providing", when used in reference 15 
to a plant, is used herein to refer to the act of delivering, 
obtaining, procuring, or the like a plant. In essence, providing 
a plant generally refers to making a plant available to one who 
wishes to collect starch from the plant. The term "collecting" 
is used herein to refer to any process or method where starch 20 
is used, obtained, cultivated, ingested, or the like. For 
example, in some embodiments starch is collected by harvest-
ing a plant that comprises starch and processing the plant in 
order to obtain starch or other sugars derived therefrom. In 
some embodiments, collecting refers to ingesting a plant that 25 
comprises a glucan phosphatase polypeptide variant. 
The structure of SEX4 to 2.4 A was determined using 
selenomethionine single-wavelength anomalous dispersion 
(SAD) (55). The structure revealed a unique set of extensive 
interdomain interactions producing a complex tertiary archi-
tecture composed of anN -terminal DSP domain, CBM, and a 
C-terminal domain (FIG. 4). The novel C-terminal domain is 
structurally integrated into the DSP domain. Extensive DSP-
CBM interactions position the DSP active site in alignment 
The presently -disclosed subject matter is further illustrated 
by the following specific but non-limiting examples. Some 
examples are prophetic. Some of the following examples may 
include compilations of data that are representative of data 30 
gathered at various times during the course of development 
and experimentation related to the presently-disclosed sub-
ject matter. 
with the CBM binding site, and a long deep channel is formed 
by the CBM-DSP interface (FIG. 3A-3C). In addition, the 
CBM binding site and DSP active site are separated by 21 A, 
suggesting that a glucan composed of five to six glucose 
moieties spans this region. All of these features differentiate 
SEX4 from phosphatases that dephosphorylate proteina-
ceous substrates. 
EXAMPLES 
Example 1 
IdentifYing and Characterizing Structure of Glucan 
Phosphatases 
In the following examples various assays are used to iden-
tifY and characterize the structure of glucan phosphatases. A 
glucan-binding assay was used to assess interactions between 
glucan phosphatases and glucans (Gentry (2007), Gentry 
(2009), Worby (2006), Vander Kooi (2010), Hsu (2009)). 
Amylopectin with a protein of interest was incubated and 
thereafter a high-speed spin was performed and proteins in 
the pellet and supernatant were analyzed via Western analy-
sis. Proteins binding glucans pellet with the glucan, whereas 
those not binding remain in the supernatant. To test generic 
activity, a phosphatase assay using the exogenous substrate 
para-nitrophenyl phosphate (pNPP) or 3-0-Methylfluores-
cein (OMFP) was implemented, which can also determine 
kinetic parameters (Gentry (2007), Gentry (2009), Santelia 
(2011 ), Kotting (2009), Worby (2006), Dukhande (2011 )). 
Most DSPs can cleave pNPP or OMFP, resulting in a colori-
metric change. 
Furthermore, to test glucan phosphatase activity and glu-
can binding, an assay based on the complex formation of 
malachite green with phospho-olybdate to measure inorganic 
phosphate release was implemented (Van Veldhoven (1987)). 
The glucan phosphatase assay measures the release of inor-
ganic phosphate from any phospho-glucan. Using this assay, 
it was demonstrated that mutations in the CBM oflaforin and 
SEX4 that reduce or abolish glucan binding also reduce or 
eliminate glucan phosphatase activity (Gentry (2007)). While 
Like Sex Four2 (LSF2) is another glucan phosphatase. 
35 Knowing the SEX4 structure, it was determined that LSF2 
contains a similar CT-domain as SEX4. The LSF2 cTP and 
DSP domain are 30% and 63% similar to SEX4, respectively, 
but LSF2 lacks a CBM (FIG. 4). The above-described assays 
were utilized to find that LSF2 is a glucan phosphatase 
40 because it binds and dephosphorylates phosphoglucans, 
whereas phosphatases from every other phosphatase family 
do not (FIG. SA, FIG. SE). In the assay it was discovered that 
LSF2 only removes phosphate from the C3 position and not 
the C6 position (FIG. 6) (Santelia (2011)). Subsequently, 
45 plants lacking LSF2 were shown to have increased levels of 
C3-phosphorylated starch and that lsf2 sex4 double mutant 
plants exhibited an exacerbated starch excess phenotype (21 ). 
LSF2 independently binds and dephosphorylates starch 
(FIG. SA-SE) (Santelia (2011)). Therefore, without being 
50 bound by theory or mechanism, it is believed that the LSF2 
DSP and/or CT domains contain previously unrecognized 
glucan-binding regions. Using bioinformatics on LSF2, 
SEX4, and laforin, two regions within the DSP domain of 
glucan phosphatases were uncovered that share remote 
55 homology to glycosyl hydrolase-like domains. Glycosyl 
hydrolases (GH) enzymes hydrolyze glycosidic bonds 
between either two or more carbohydrates or between a car-
bohydrate and non-carbohydrate (Henrissat (1991 ). 
The regions of the glucan phosphatase DSPs that resemble 
60 GH are within the variable loop and R -motif. However, quan-
tifYing glucose release of all three phophatases against glucan 
substrates detected no glycosyl hydrolase activity. Neverthe-
less, these two regions are highly conserved among proteina-
ceous DSPs, and are divergent between SEX4 and proteina-
65 ceous DSPs at the primary and secondary amino acid levels 
(VanderKooi (201 0). The structure of SEX4 and the proto-
typical DSP VHR also were found to diverge considerably. 
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Without being bound by theory or mechanism, these data 
suggest that GH-like regions play an integral role in glucan 
phosphatase function. 
Hydrogen/Deuterium Exchange Mass Spectrometry 
(DXMS) was then used to define the structural dynamics of 5 
SEX4 and which portions ofSEX4 interact with the substrate 
(Hsu (2009)). First, SEX4-HIS6 was purified from E. coli to 
>99% homogeneity, pepsin digestion conditions were opti-
mized, and the deuteration rate of each peptide for both 
ligand-free and amylopectin-bound SEX4 was determined 10 
(FIG. 7A-7E). The DXMS results were analyzed using the 
primary and predicted secondary structure of SEX4 (FIG. 
7B). It appears that the CBM undergoes increased protection 
from deuteration when bound to glucans (FIG. 7C), and struc-
tural components of the DSP domain undergo increased pro- 15 
tection upon glucan addition (FIGS. 7C and 7D). of these 
regions corresponds to the putative GH-like regions. Thus, it 
appears that SEX4 does not undergo a global conformational 
change upon glucan binding, but instead SEX4 undergoes 
minimal rearrangement upon binding, and the DSP domain 20 
makes extensive and intimate contact with phospho-glucans. 
Example 2 
18 
phatase will be swapped with that of another. Once the LSF2 
structure is completed, the LSF2 active site architecture will 
be compared to that of SEX4. Collectively, the studies will 
uncover novel aspects of each enzyme, define the inherent 
activity of each DSP domain, and determine the amino acids 
responsible for these activities. In addition, these engineered 
proteins can be used to yield different substrate specificities 
with respect to C3 versus C6 kinetics and produce designer 
starches in vitro and/or when over-expressed in planta. 
Example 3 
Characterization of Glycosyl Hydrolase Regions in 
the DSP 
As presented in Example 1, two regions within the DSP 
domain of glucan phosphatases are similar to glycosyl hydro-
lase family 1 (GH1) and family 10 (GH10) motifs and are 
located within the R-motif and variable loop, respectively, of 
the DSP domain. The R-motif is highly conserved among 
classical protein DSPs (64), but the glucan phosphatases 
share no homology with protein DSPs in this region. The 
variable loop contributes to the depth of the active site, and it 
assists in positioning the active site arginine to interact with 
Characterization of Enzymatic Activity and Specific 
Domains of Glucan Phosphatases 
In this example the differences between SEX4 and LSF2 
are characterized according to their structures. The distin-
guishing structures, including particular domains and amino 
acids, are further investigated to determine how they may be 
utilized to engineering starch. 
25 the phosphate of the substrate (Alonso (2003)). Thus, these 
regions are well positioned to assist in phospho-glucan pre-
sentation to the active site and share no homology with pro-
teinaceous DSPs, but are well conserved among glucan phos-
phatase orthologs. Since LSF2 lacks a CBM yet still 
First, a SEX4 construct that lacked a CBM (SEX4-
llCBM), making it LSF2-like, and a fusion of the 
LSF2_DSP+SEX4_CBM/CT were generated and yielded 
soluble recombinant protein (FIG. SA-C). The chimeras were 
both found to possess generic/pNPP phosphatase activity and 
glucan phosphatase activity. The LSF2+CBM fusion had 
increased binding to amylopectin (FIG. SD), but did not 
exhibit increased glucan phosphatase specific activity (FIG. 
SA). These results suggest that the engineered LSF2 enzyme 
has increased glucan binding compared to LSF2, but that the 
LSF2+CBM fusion is unable to dephosphorylate any more 
phospho-glucans than LSF2-WT. Without being bound by 
theory or mechanism, the LSF2+CBM fusion is likely only 
dephosphorylating the C3-phosphate that accounts for -30% 
of phosphate within starch. Subsequently, the dephosphory-
lation kinetics and the activity of the other chimeras will be 
examined using the C3 versus C6 dephosphorylation assay. 
30 possesses glucan phosphatase activity, this Example investi-
gates whether these regions coordinate glucan presentation to 
the LSF2 active site by binding and positioning phosphoglu-
cans to promote dephosphorylation. 
Mutations in both GH -like regions ofLSF2 were generated 
35 to determine if the bioinformatics analyses identified regions 
within the DSP domain ofLSF2 necessary for glucan dephos-
phorylation. The proteins were purified and tested for their 
generic and glucan phosphatase activities. The mutants 
retained similar specific activities to LSF2, but their glucan 
40 phosphatase specific activities are dramatically decreased. 
Corroborating these results is the fact that several point 
mutations in these two regions within laforin cause Lafora 
disease (GH10-like: T187 A&T1961, andGH1-like: Q293L, 
Y294N, P301L). Thus, these point mutations may diminish 
45 the ability of the laforin DSP domain to interact with and 
dephosphorylate phospho-glucans, supporting the notion that 
GH-like regions within the DSP domain play an important 
role in glucan dephosphorylation. 
Alanine scanning was performed by mutating blocks of 
50 amino acids in these regions to alanine (i.e. for SEX4 we will 
mutate DPDL in the R-motifto AAAA). Glucan phosphatase 
activity of SEX4 and LSF2 will be tested to see if it is inhib-
ited by mutating blocks of amino acids in these regions, while 
not affecting or minimally affecting generic phosphatase 
Each glucan phosphatase contains the classical active site 
residues (Dx20HCx5 R), but they contain differences within 
this region. Laforin is the only glucan phosphatase that con-
tains all of the consensus catalytic site residues that are his-
torically known to affect dephosphorylation efficiency, i.e. 
Dx20HCxxGxxRS/T (i.e. Cx5R). These residues actively par-
ticipate in dephosphorylation (D, C, R), contribute to the 
architecture of the active site (G), or decrease the pKa of the 
active site Cys (Hand S/T) (Alonso (2003)). SEX4 and LSF2 
both possess a terminal Ala instead of the typical Ser/Thr, and 
may possess different preferences and/or perform dephos- 60 
phorylation with different kinetics. The active site residues 
likely impose steric hindrance against either a C3- or 
C6-bound phosphate, thus impacting specificity. 
55 activity (i.e. pNPP). The C3/C6 assay will determine catalytic 
efficiencies of these mutants and determine if the mutations 
affect specificity. 
Since SEX4 and LSF2 have relatively lower specific activ-
ity for dephosphorylating phospho-glucans, their catalytic 
efficiencies will be observed after mutating their GH1- and 
GH10-like regions to match the GH1 and GH10 consensus 
sequences. Enhancing glucan phosphatase activity by mutat-
ing one and/or both of these regions further strengthens the 
notion that these regions play an important role in glucan 
dephosphorylation. 
To define the amino acids contributing to glucan phos-
phatase activity and specificity, each catalytic site will be 65 
mutated and the activity of the mutants analyzed using the 
assays in Example 1. Initially, the Cx5R of one glucan phos-
These experiments will determine if the glucan phos-
phatase activity of SEX4 and LSF2 can be separated from 
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generic phosphatase activity as well as the kinetics of glucan 
dephosphorylation. This will show the role of the different 
domains, including the GH-like regions within their DSP 
domains, and amino acids in directing glucan dephosphory-
lation. These findings will provide one or more regions to 5 
target with a small molecule to modulate glucan phosphates 
activity to eventually modulate energy stores. 
Example 4 
20 
ties, in buffers of similar composition, and to similar yields as 
the respective wild type protein. 
DXMS experiments similar to those outlined above will be 
carried out on mutant LSF2 and SEX4. Mutants can be 
selected for analysis based on data from Example 3, being 
most interested in 1) mutants that increase glucan phos-
phatase activity and 2) those that retain glucan binding and 
pNPP/generic phosphatase activity while exhibiting 
decreased glucan phosphatase activity. The HID exchange 
Characterization of Structural Dynamics and/or 
Substrate Binding Site of Glucan Phosphatases with 
Hydrogen/Deuterium Exchange Mass Spectrometry 
(H/DXMS) 
1 o rate for the ligand-free mutants will be defined, and the results 
will determine if the mutations cause global conformational 
changes, or if they cause minimal to no change in their con-
formation. With these results one can determine the structural 
dynamics and/or glucan binding of mutants when they bind 
15 amylopectin or oligosaccharides. 
As discussed in Example 1, H/DXMS has been used to 
determine the structural dynamics and glucan binding sites of 
SEX4, and its structure was determined using x-ray crystal-
lography (55 ,58). These results indicate the structural dynam- 20 
ics ofSEX4, that specific regions within the DSP domain of 
SEX4 intimately interact with phospho-glucans, and the 
SEX4 variable loop undergoes the most dramatic substrate-
induced protection from deuteration (FIG. 4). While LSF2 is 
a glucan phosphatase, there are substantial differences 25 
between the two proteins. This Example will determine how 
glucan phosphatases, including LSF2, interact with starch, 
modulate starch dephosphorylation, and elucidate their role 
in energy release. 
Greater than 99% pure glucan phosphatases were produced 30 
with a two-step purification process using an HIS-affinity 
colunm and Profinia system (BioRad) followed by gel filtra-
tion chromatography with a HiLoad 26/60 Superdex 200 and 
AKTA Purifier (GE), which purified ""25 mg of soluble SEX4 
and LSF2/liter of E. coli cells (Vander Kooi (2010), Hsu 35 
(2009)). 
To define LSF2 digestion conditions to maximize MS/MS 
mass spectrometry coverage, LSF2 digestion was tested 
under similar conditions that were optimal for SEX4, 0.5 M 
guanidine hydrochloride and 1 M Tric-2-carboxyethyl phos- 40 
phine (reducing agent) with a pepsin column, and the peptide 
products will then undergo LC-MS/MS analyses. Once these 
conditions were optimized, the HID exchange ofligand-free 
LSF2 at eight time points from 10 s to 1 O,OOOs (166 minutes) 
was determined. These data was combined with the LSF2 45 
peptide map ofLSF2, as was done for SEX4 in FIG. 7A, to 
determine which regions of LSF2 are more or less accessible 
to HID exchange. 
The same experiment will also be performed in the pres-
ence of a glucan. In SEX4 DXMS studies, both large glucans 50 
(amylopectin) and small glucans (~-cyclodextrin) interact 
with the SEX4 DSP domain (FIG. 7A-7E) (Hsu (2009)). 
Here, the small, homogenous ringed-glucan ~-cyclodextrin; 
the small homogenous linear maltohexaose; and the large, 
heterogeneous, highly phosphorylated glucan amylopectin 55 
will be utilized. Methodologies to immobilize SEX4 and 
LSF2 on SPR chips and binding experiments with each pro-
tein and multiple oligosaccharides will use a Biacore TlOO 
(GE Healthcare). Thus, this Example defines the interaction 
between LSF2 with multiple glucans at a molecular resolu- 60 
tion, and the binding affinities for LSF2 and SEX4 with 
multiple glucans, the outer and inner surfaces via DXMS. 
Once the analysis of wild type LSF2 by DXMS is opti-
mized, DXMS will be used to probe the structural dynamics 
of the GH-like regions ofLSF2 mutants and SEX4 mutants 65 
discuss above. Notably, out of32 SEX4 mutants and 12 LSF2 
mutants that have been generated, all purifY to similar puri-
If the GH-like regions are necessary for positioning the 
phospho-glucan, then the DXMS results of the mutant pro-
teins should show a substantial decrease in substrate-induced 
protection from HID exchange. However, if the GH-like 
regions play little role in positioning and binding the phos-
pho-glucan, then there should be minimal change in the rate 
of substrate-induced HID exchange between mutants and 
wild type proteins. Once the motifs within the DSP domain 
that interact with glucans are identified, they can be targeted 
with point mutations and/or small molecules to increase/ 
decrease glucan phosphatase activity. 
Example 5 
Characterization of Glucan Phosphatases Crystal 
Structure 
This Example will determine how glucans are accommo-
dated by glucan phosphatases that have a CBM (i.e. SEX4) 
and those that lack a CBM (i.e. LSF2), the characteristics that 
yield specificity for different types of substrates (i.e. C3 v. C6 
and soluble v. crystalline), and how such activity can be 
modified. 
LSF2 primary sequences from multiple species were ana-
lyzed using prediction programs to define domain bound-
aries, establish predicted secondary structure, predict regions 
of disorder, and define regions of hydrophobicity. Based on 
these data, the full-lengthArabidopsis LSF2 gene was cloned 
as well as multiple truncations that remove different sections 
of the chloroplast Targeting Peptide (cTP). Similar method-
ologies successfully guided SEX4 cloning strategies (Vander 
Kooi (2010)). 
Full length LSF2 was largely insoluble when expressed in 
E. coli, but ll78-LSF2 produced large amounts of soluble 
protein. !178-LSF2 was purified to homogeneity using a two-
step purification process as discussed in Example 4. 30-40 mg 
of soluble ll78-LSF2/L of E. coli, was produced and made in 
a concentration of> 15 mg/ml that it is stable for >2 weeks at 
4o C. 
A mosquito crystallization robotics station (TTP Labtech) 
was used to identifY conditions that produced LSF2 diffrac-
tion quality crystals (VanderKooi (2010). Many crystalliza-
tion conditions were screened with minimal total protein 
requirements. The default protocol involved performing 
hanging drop vapor diffusion experiments in 96-well plates 
with three drops per well. The three drops were each 200 nL 
and had differing protein:mother liquor ratios (typically 3:1, 
1:1, 1:3), which required 42 f.LL for the 288 conditions in each 
96 well plate. 
Initially, the process comprised multiple sparse matrix 
commercial screens and then several rounds of optimization 
before obtaining crystals of sufficient dimensions to analyze 
US 9,410,133 Bl 
21 
(at the UK Center for Structural Biology core facility). Full 
datasets to -3.5 A and to -1.65 A at the SER-CAT beamline 
were collected at the Advanced Photon Source (Argonne 
National Laboratory) (FIG. 9A-9C). Molecular replacement 
was suitable for deriving initial phases of LSF2. These data 5 
are being iteratively refined using Refmac and coot (FIG. 
9A-9C) (Emsley (2004), Murshudov (1997)). 
The above described SEX4 structure was a glucan-free 
structure (FIG. 3A-3C) (VanderKooi (201 0)). Given the het-
erogeneity of starch, it has proven difficult to correctly model 10 
a glucan chain into the SEX4 glucan binding pocket. Observ-
ing the structure, 21 A separate the CBM binding site and the 
DSP active site, which is enough distance for a 5-6 glucose 
chain (i.e. maltopentaose or -hexaose). Determining a struc-
ture with bound glucan would shed light on the residues that 15 
directly interact with the glucan. Therefore, crystallization 
was studied in the absence and presence of phosphate plus 
multiple glucan additives including maltotetraose, malto-
hexaose, maltopentaose, maltotriose, a-maltosyl-~-cyclo­
dextrin, and others. Several conditions yielded crystals with 20 
SEX4, which will be analyzed as described above. Similar 
studies will also be done with LSF2. These results will be 
enhanced by, but do not depend on, SPR and ITC analyses. 
22 
of native LSF2 protein. Cells were grown at 37° C. in 2xYT 
media to OD600=0.6-0.8, placed on ice for 20 min, induced 
with 1 mM isopropyl ~-D-thiogalactoside (IPTG), grown at 
16° C. for 16 hr, and harvested by centrifugation. Cells were 
lysed in 20 mM Tris-HCl (pH 7 .5), 100 mM NaCl, and 2 mM 
dithiothreitol (DTT), centrifuged, and the proteins were puri-
fied via a Profinia IMAC Ni2+ column (Bio-Rad) with a 
Profinia protein purification system (Bio-Rad). Protein was 
dialyzed in 20 mM Tris-HCl (pH 7.5), 100 mM NaCl, and 2 
mM dithiothreitol (DTT) overnight at 4 o C. in the presence of 
thrombin. Affinity purified protein was then reverse purified 
over the Profinia IMAC Ni2 + column and the flow-through 
fraction was collected. Protein was further purified to homo-
geneity using a HiLoad 26/60 Superdex 200 size exclusion 
column (GE Healthcare ). Protein used for enzyme and bind-
ing assays were stored in 10% glycerol as a cryoprotectant 
and flash frozen for later use. 
Recombinant potato GWD and recombinant Arabidopsis 
PWD for 33P labeling of Arabidopsis starch were purified as 
previously described with the following modifications (Ritte 
(2002), Kotting (2005)). GWD and PWD were transformed 
into BL21-CodonPlus E. coli cells and expressed similarly to 
ll78-LSF2 as stated above. GWD was lysed in buffer (50 mM 
Tris/HCl pH 7.5, 2.5 mM EDTA, 2.5 mM DTT, 0.5 mM The glucan-free structure ofSEX4 uncovered a number of 
interesting structural features regarding glucan dephosphory-
lation, including 1) adaption of multiple phosphatase motifs 
to accommodate interdomain interactions, 2) a novel CT 
domain that is structurally integrated with the DSP domain, 3) 
alignn1ent of the DSP active site with the CBM glucan bind-
ing pocket and separated by 21 A, 4) motifs allowing a 10° 
rotation of the CBM-DSP pockets that may allow processive 
substrate dephosphorylation, and 5) a charmel formed by the 
CBM-DSP interface capable of accommodating both phos-
pho-oligosaccharides as well as a more crystalline substrate 
(e.g. starch) (55). As discussed above, certain regions within 
SEX4 may account for these structural and functional fea-
tures and multiple point mutations have been generated to 
investigate these aspects of glucan dephosphorylation. Simi-
25 PMSF), and proteins were purified using an anion exchange 
column (Q-sepharose-FF, GE-Healthcare) with a salt gradi-
ent (50 mM Tris/HCl pH 7.5, 2.5 mM EDTA, 2.5 mM DTT, 
0.5 mM PMSF, 0.5 NaCl) to elute the protein. Fractions were 
collected and protein was further purified using a HiLoad 
lar experiments will be conducted for LSF2 to further define 
glucan phosphatases in general. This Example will define the 
subregions within the DSP domain that bind glucans and 
determine the characteristics that yield specificity for differ-
ent types of glucans. 
Cloning, Expression, and Purification of Recombinant Pro-
teins 
Cloning of full length Arabidopsis thaliana LSF2 from 
eDNA was previously described (Santelia (2011 )). Based on 
data from secondary structure predictions, disorder predic-
tions, sequence homology with SEX4, and analysis ofLSF2 
orthologs, we generated an A. thaliana LSF2 construct lack-
ing the first 78 amino acids (ll78-LSF2).ll78 LSF2 does not 
contain the cTP (predicted to be residues 1-65) along with 
residues up to the DSP recognition domain. ll78-LSF2 was 
subcloned into pET28 (Novagen) using Ndei and Xhoi sites 
30 26/60 Superdex 200 size exclusion colunm (GE Healthcare) 
innewbuffer(100mMMOPS/KOHpH7.6, 1 mMEDTA, 2 
mM DTT, 0.5 mM PMSF, 150 mM NaCI). GWD was then put 
over a desalting colunm using a Bio-Scale Mini Bio-Gel P6 
Desalting colunm (Bio-Rad) using a Profinia protein purifi-
35 cation system (Bio-Rad). PWD was lysed in buffer (50 mM 
HEPES/NaOH pH 8.0, 300 mM NaCl, 10 mM imidazole, 0.5 
mM PMSF), centrifuged, and proteins were purified using a 
Profinia IMAC N?+ colunm (Bio-Rad) with a Profinia pro-
tein purification system (Bio-Rad). PWD was further purified 
40 using a HiLoad 26/60 Superdex 200 size exclusion column 
(GE Healthcare). 
Crystal Structure Determination and Refinement 
For glucan bound crystals single, high quality crystals, 
with one molecule in the asymmetric unit, were obtained via 
45 hanging drop vapor diffusion using a Mosquito liquid han-
dling robot (TTPLabtech) using a 200 nL drop with a 1:3 ratio 
of ll78-LSF2 C193S (4.8 mg/mL) preincubated with 25 mM 
maltohexaose (Sigma-Aldrich): 0.1M di-ammonium hydro-
gen phosphate (pH 5.7), 17% 2-propoanol, and 31% PEG 
50 4000 at 18° C. Single, high quality ll78-LSF2 wild-type crys-
tals, with one molecule in the asymmetric unit, were obtained 
with a 200 nL drop using a 1:1 ratio ofLSF2 (4.8 mg/mL): 
0.1M tri-sodium citrate (pH 5.8), 16% 2-propanol, 31% PEG 
4000, and 2% glycerol at 18° C. A single crystal was used for 
55 data collection and structural determination for both LSF2 
structures. Both ll78-LSF2 C193S (phosphate/malto-
hexaose) and ll78-LSF2 wild-type (citrate) data were col-
lected on the 22-ID beamline of SER-CAT at the Advanced 
to encode a His6 tag, a thrombin cleavage site, and ll78-LSF2 
(Santelia (2011)). All point mutants were generated using a 
site-directed mutagenesis kit (Agilent) or mutagenesis ser-
vices (GenScript). Cloning and purification of A. thaliana 
SEX4 lacking the first 89 amino acids (ll89-SEX4) (Vander 
Kooi (2010)) and Hs-VHR (Yuvaniyama (1996)) was per- 60 
formed as previously described. All DNA sequencing (ACGT 
Inc.) was confirmed using Mac Vector. Amino-acid sequences 
ofLSF2 orthologs were aligned with ClustalW in Mac Vector. 
Expression and purification of ll78-LSF2 was performed 
similarly to the previously described method for ll89-SEX4 65 
(VanderKooi (2010)). Briefly, BL21-CodonPlus E. coli cells 
were transformed with expression vectors for the production 
Photon Source, Argonne National Laboratory (Table 1) at 
110K at a wavelength of 1.0 A. Data was processed using 
HKL2000 (Otwinowski and Minor (1997)). PHENIX (Ad-
ams (2010)) was used for molecular replacement using the 
SEX4 DSP and 010 helix of the SEX4 CT domain as search 
models (VanderKooi (2010)). The structures were then fully 
built and refined via iterative model building and refinement 
using Coot (Emsley (2010)) and Refmac5 (Murshudov 
(1997) ), respectively. Stereochemistry of the model was ana-
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lyzed using MolProbity (Davis (2007)). Analysis and 
molecular graphics were prepared using Pymol (Schrodinger, 
2010). Density maps were produced using the FTT program 
in CCP4 (Winn eta!.). Comparative structure analyses were 
performed using the DaliServer (Holm and Rosenstrom, 
2010) and DaliLite (Hasegawa and Holm (2009)). Protein-
ligand contact analyses were performed with Areaimol (Lee 
and Richards (1971) ). We deposited the models and structure 
factors to the Protein Database (PDB) under the file names 
4KYR (ll78-LSF2 C193S-maltohexaose/phosphate) and 
4KYQ (!178 LSF2 wild-type). 
Phosphatase Assays 
Phosphatase assays using pNPP have been previously 
described and were performed with the following modifica-
tions (Worby (2006), Gentry (2007), Sherwood (2013)). 
Hydrolysis of p-NPP was performed in 50 f.LL reactions, con-
taining 1x phosphatase buffer (0.1 M sodium acetate, 0.05 M 
bis-Tris, 0.05 M Tris-HCl pH 7.0, 2 mM dithiothreitol), 50 
mM pNPP, and 1 flg of enzyme at 37° C. for 15 min. The 
reaction was terminated by the addition of 200 f.LL of 0.25 
NaOH and absorbance was measured at 410 nm. The assay 
was performed with each protein 2:6 times to determine spe-
cific activity. 
24 
rotating wheel for 5 min at 25° C. The reaction was terminated 
by the addition of 50 f.LL 10% SDS. The reaction tubes were 
then centrifuged at 13,000 rpm for 5 minutes to pellet the 
starch. 33P release into 150 flL of supernatant was determined 
5 using a 1900 TR liquid scintillation counter (Packard). The 
assay was performed with each protein s6 times to determine 
specific activity. 
Glucan Binding Assay 
Glucan-binding assays were performed as previously 
10 described with the following modifications (Gentry (2007), 
Dukhande (2011)). All proteins used in the glucan-binding 
assays were purified as described above without cleavage of 
the His6 tag to maintain the epitope for western blot analysis. 
Amylopectin, from potato starch (Sigma) was solubilized by 
15 the Roach method (Wang and Roach (2004)) at a concentra-
tion of 5 mg/mL. 5 mg of amylopectin was then pre-pelleted 
via centrifugation at 50,000 rpm for 1.5 hrs at 4 o C. to collect 
only pelletable amylopectin and then resuspended in 0.5 mL 
binding buffer (50 mM Tris, 150 mM NaCl, pH 7.5, 2 mM 
20 DTT). 1 flg of recombinant protein was incubated in amy-
lopectin solution for an hour at 4° C. with rocking. The 
solution was then centrifuged at 50,000 rpm for 1.5 hrs. 
Co-sedimentation with amylopectin was measured by centri-
fuging the samples at 50,000 rpm for 1.5 hrs. All supernatant 
25 
was removed and protein was precipitated with 4 volnmes of 
acetone stored at -20° C. Precipitated protein was then pel-
leted via centrifugation at 15,000 rpm for 30 minutes and 
excess acetone was removed using a SpeedVac concentrator 
(Savant) at 65° C. for 1.25 hr. Both soluble and pellet fractions 
Phosphate release from 33P-Labeled granules was per-
formed as previously described with the following variations 
(Hejazi (2010), Santelia (2011)). C6-33P-labeled starch was 
generated by isolating phosphate-free starch granules from 
theArabidopsis sex1-3 mutant (Yu (2001)), phosphorylating 
the starch with 33P at the C6-position by GWD followed by a 
stringent wash. Phosphorylation with unlabeled ATP at the 
C3-position by PWD was performed as previously described 
(Hejazi (2010)). C3-33P-labeled starch was generated by iso-
lating phosphate-free starch granules from the Arabidopsis 
sex1-3 mutant (Yu (2001)), phosphorylating the starch with 
unlabeled ATP at the C6-position by GWD followed by a 35 
stringent wash and phosphorylation with 33P at the C3-posi-
tion by PWD as previously described (Hejazi (2010)). In both 
cases the starch granules were phosphorylated at both posi-
tions, however the 33P-label was located at only one or the 
other position. [~-33P]ATP was obtained from Hartmann 40 
Analytic. Recombinant proteins (150 ng) were incubated in 
dephosphorylation buffer (100 mM sodium acetate, 50 mM 
bis-Tris, 50 mM Tris-HCl, pH 6.5, 0.05% [v/v] TritonX-1 00, 
30 
were then resuspended in 30 flL RIPA buffer before the addi-
tion of30 f.LL SDS-PAGE buffer (60 f.LL total volume for both 
the soluble and pellet fractions). 15 f.LL of the pellet and 
soluble fraction were then resolved via SDS-PAGE and rela-
tive concentration of pellet and soluble protein was analyzed 
by immunoblotting with a-His 6 antibody. Quantification of 
the signal was determined using ImageJ (Abramoff (2004)). 
The assay was performed 03 times with each protein to 
determine binding capacity. 
Crystal Structure ofLSF2 Bound to Maltohexaose and Phos-
phate 
The structure of the Arabidopsis thaliana LSF2 glucan 
phosphatase (residues 79-282, C193S) bound to malto-
hexaose and phosphate was determined to a resolution of2.30 
A using molecular replacement with one molecule in the 
asymmetric unit (FIG. 9A, Table 3). 
1 flg/flL [w/v] BSA, and 2 mM DTT) with C6- or C3-pre-
labeled starch (4 mg/mL) in a final volnme of 150 f.LL on a 
Crystal 
Data collection 
Space group 
Cell dimensions 
a, b, c (A) 
a, i),y (c) 
Wavelength (A) 
Resolution range (A) (highest shell 
resolution) 
Rnerge (highest shell) 
II al (highest shell) 
Completeness(%) (highest shell) 
Redundancy (highest shell) 
Refinement 
Resolution (A) 
TABLE3 
Crystallographic Statistics 
L\.78-LSF2 C193S-
maltohexaose, phosphate 
P6522 
92,78, 92.78, 144.94 
90, 90, 120 
1.00 
20.0-2.30 (2.38-2.30) 
10.8 (39.1) 
9.0 (2.2) 
94.8 (87.3) 
3.7 (2.5) 
2.30 
L\.78-LSF2 WT-
citrate 
P21212 
51.82, 99.58, 37.76 
90, 90,90 
1.00 
20-1.65 (1.71-1.65) 
6.6 (59.3) 
20.5 (2.3) 
90.1 (86.3) 
4.7 (4.7) 
1.65 
US 9,410,133 Bl 
25 26 
TABLE 3-continued 
Crystallographic Statistics 
Crystal 
L\.78-LSF2 C193S-
maltohexaose, phosphate 
L\.78-LSF2 WT-
citrate 
No. reflections 
~orJ!Rfree 
No. atoms 
Protein 
Ligand/ion 
Water 
B-factors 
Protein 
Ligand/ion 
Water 
RMSDs 
Bond lengths (A) 
Bond angles (0 ) 
Ramachandran Plot 
Most favored regions (%) 
Additional Allowed regions (%) 
Disallowed regions (%) 
15288 
17.3/22.9 
1685 
251 
88 
41.6 
37.6 (phosphate) 
70.1 (maltohexaose, active site) 
59.0 (maltohexaose, site-2) 
60.7 (maltohexaose, site-3, hex-1) 
86.1 (maltohexaose, site-3, hex-2) 
49.6 
0.014 
2.1 
97.6 
2.4 
0.0 
The LSF2 DSP domain (residues 79-244) possesses a char-
acteristic core PTP fold consisting of a central five-stranded 
~-sheet region flanked by eight a-helices (FIG. 10). The CT 
motif (residues 245-282) consists of a loop region culminat-
ing in an a-helix that integrally folds into the DSP domain, a 
characteristic also found in the glucan phosphatase SEX4 
(VanderKooi (201 0)). A search for structural homologues of 
the LSF2 DSP domain (residues 79-244) identifies the DSP 
domain ofArabidopsis SEX4 (residues 90-250, R.M.S.D. 1.1 
A, PDB 3NME (VanderKooi (2010)) and mouse PTPMTl 
(residues 105-256, R.M.S.D. 2.2 A, PDB 3RGQ (Xiao 
(2011)) as the structures most similar to LSF2 despite the fact 
that the LSF2 DSP is only 48% and 17% identical at the 
amino acid level to the DSP domain of SEX4 and PTPMTl, 
respectively. 
Maltohexaose is comprised of six glucose moieties with 
a-1 ,4-glycosidic linkages, thus it is similar to the unwound 
helices on the starch granular surface. In the structure, mal-
tohexaose is bound to the LSF2 active site and two distal sites. 
20833 
15.7/19.9 
1717 
13 
161 
13.3 
14.5 (citrate) 
31.5 
0.014 
1.7 
98.0 
2.0 
0.0 
chain position and orientation, labeled Glc1-Glc6 from the 
30 non-reducing end to the reducing (FIGS. 9D and 12A,B). 
35 
Strikingly, the 03 group of Glc3 is directly interacting with 
the phosphate at the LSF2 catalytic site at a distance of 2.4 A 
compared to 7. 0 A for the 06 group. Furthermore, the orien-
tation of the PTP catalytic triad (DX30_35CX5R) within LSF2 
is proximal to the 03 and phosphate and poised for catalysis 
of a C3-phosphorylated glucose (FIG. 9E). C193S is located 
at the base of the active site cleft, 2.5 A from the nearest 
phosphate oxygen, and represents the key nucleophilic cata-
40 lytic residue that covalently attacks the phosphate group dur-
ing catalysis. R199 is positioned 2.8 A from the phosphate, 
and assists in presenting the phosphate of the substrate to the 
catalytic cysteine. At the top of the active site cleft is the 
D-loop D161 that participates in catalysis as a general acid/ 
45 base, forming the reaction intermediate and then assisting in 
hydrolysis and product expulsion. D 161 is located 2.5 A from 
the 03 ofG!c3 and 3.8 A from the nearest phosphate oxygen. 
Maltohexaose-Phosphate Product Bound at the LSF2 Active 
Site The LSF2 active site region contains a single maltohexaose 
chain and phosphate molecule within the catalytic pocket. 50 
Multiple conserved DSP active site motifs converge to form 
Five highly conserved aromatic residues delineate the 
boundaries of the extended active site channel, forming 
extensive interactions with the glucose rings of the malto-
hexaose chain (FIG. 13A). These five aromatic residues pro-
vide the majority of the interface between the LSF2 active site 
and the substrate. Y83, Y85, Y135 and W136 form one side of 
the channel and interact with glucose moieties Glc1-5. Y83 
an extended active site binding pocket within LSF2 that is -19 
A long and -9 A deep with 511 A2 contact area (FIG. 9B). 
These motifs include: a recognition domain from a1 through 
~ 1 (83-92), variable (V-)loop from a3 through a4 (132-150), 55 
a WPD (D-)loop between ~4 and a5 (158-163), a PTP-loop 
between ~5 and a6 (192-199) that contains the LSF2 active 
site, and an R-motifbetween a7 and aS (225-244) (FIGS. 10 
and 11). 
and Y85 are located within the recognition domain, directly 
adjacent to the R-motif and PTP-loop, respectively. Y135 and 
W136 are both located in the V-loop and form a continuous 
LSF2 C3-Specificity and Catalytic State 60 interaction surface with Y85. F162, located in the D-loop, 
forms the opposite side of the aromatic channel and interacts 
with Glc2-6. These glucose moieties form a helical structure 
around F 162 and interact with both faces of the pheny !alanine 
LSF2 possesses robust activity against starch and displays 
high specificity for the C3 position, as measured by a 33P-
radiolabeled starch dephosphorylation assay (FIG. 9C) (San-
telia (2011 )). While both glucan dikinases and glucan phos-
phatases display strong positional specificity, the basis of this 65 
specificity is unclear. The electron density of the malto-
hexaose in the active site allows clear assignment of glucan 
ring. The residues that form the aromatic channel are strictly 
conserved in all land plants as well as in most single-celled 
members of Kingdom Plantae, with only one non-conserva-
tive substitution (Volvox carteri L83, FIG. 11). 
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To investigate the functionality of theses aromatic residues, 
we generated alanine mutants of each channel residue and 
tested their ability to dephosphorylate starch granules iso-
lated from Arabidopsis. Single alanine point mutations of 
Y83, Y85, Y135, W136, and F162 resulted in a decrease of 5 
C3-dephosphorylation by 38-96% (FIG. 13B). Mutation of 
both sides of the channel (W136A/F162A) resulted in a 99% 
loss of glucan phosphatase activity. Importantly, the observed 
decreases in specific glucan phosphatase activity were not 
due to destabilization of the active site or misfolding of the 10 
protein as evidenced by near wild-type phosphatase activity 
for all mutant proteins towards the generic substrate para-
nitrophenyl phosphate (pNPP) (FIG.14A). Thus, our findings 
indicate that LSF2 possesses an aromatic channel that forms 
an extended active site uniquely suited to bind to poly-glucan 15 
substrates and necessary for glucan phosphatase activity. 
Conformational Changes in the LSF2 Active Site 
Intriguingly, one of these key aromatic residues, F 162, is 
found in the D-loop directly after D161 that serves as the 
general acid/base, discussed above. In fact, F162 makes the 20 
most contact of any active site residue with the substrate 
glucan, (136 A2 , 27% of the total contact area). To compare 
the catalytic site of glucan-bound and unbound LSF2, we 
crystallized LSF2 without maltohexaose and determined the 
structure to a resolution of 1.65 A using molecular replace- 25 
ment (FIG. 15, Table 3). The glucan-free LSF2 produced a 
different crystal form and contained one molecule in the 
asymmetric unit and bonnd citrate from the crystallization 
buffer (FIG. 15). The R.M.S.D. of the glucan and citrate-
bound DSP domain (residues 79-244) structures is 1.0 A. A 30 
comparison of product-bound and citrate-bound LSF2 struc-
tures revealed a substrate-dependent rearrangement of the 
D-loop architecture upon glucan binding (FIG. 13C). In the 
product bound structure, the orientations of D 161 and F 162 
are significantly different. The D-loop aromatic residue F 162, 35 
important for the specific activity of LSF2, interacts with 
multiple subunits of the glucan and shifts towards the V-loop. 
This movement is associated with a significant reorientation 
of the critical general acid/base, residue D161. Comparison 
of the two structures reveals that the terminal carboxylate of 40 
D 161 is 3.1 A closer to the catalytic cysteine and directly in 
contact with the 03 group of Glc3. To further analyze the 
position ofD 161, we compared the LSF2 DSP with structures 
of the glucan phosphatase SEX4, and the prototypical protein 
phosphatases VHR (PDB 1VHR (Yuvaniyama (1996)) and 45 
SSH-2 (PDB 2NT2 (Jnng (2007)). Analysis of the catalytic 
triad from each of these structures reveals that the substrate-
bound orientation of LSF2 D 161 is in a catalytically compe-
tent orientation only in the product bound structure (FIG. 16). 
Thus, LSF2 undergoes a substrate-induced conformational 50 
change with the LSF2 product bonnd form ideally positioned 
for catalysis of an 03 phosphorylated glucan substrate. 
Most DSPs possess a short chain hydrophilic reside, S/T/ 
NIH, at the + 1 residue from the general acid/base aspartate 
(VanderKooi (2010)). However, F162 is invariant in LSF2 55 
and the corresponding residue is also strictly conserved in 
SEX4, F167. We previously demonstrated that mutating 
SEX4 F167 to a short chain hydrophilic residue (F167S) 
resulted in a 50% decrease in the glucan/pNPP phosphatase 
activity ofSEX4 F167S (VanderKooi (201 0)). Cumulatively, 60 
these data demonstrate an important role forD-loop move-
ment in order to correctly position the catalytic triad and 
maximize glucan phosphatase activity. 
Non-Catalytic Glucan Binding Sites 
Glucan phosphatases were originally defined as enzymes 65 
that contain both a DSP and CBM domain, and the CBM has 
been shown to be critical for endogenous substrate binding 
28 
and biological actlVlty (Gentry (2007), Gentry and Pace 
(2009)). Because LSF2 lacks a CBM the nature of its sub-
strate binding ability has been nuclear. Therefore, we inves-
tigated LSF2 glucan binding to amylopectin. LSF2 was incu-
bated with amylopectin, the amylopectin was then pelleted by 
ultracentrifugation. Proteins in the pellet (P) and supernatant 
(S) were separated by SDS-PAGE, and visualized by Western 
analysis. The prototypical protein phosphatase VHR does not 
bind amylopectin and is found in the supernatant whereas the 
prototypical glucan phosphatase SEX4 possesses robust glu-
can binding and is largely in the pellet (FIG. 17A). LSF2 also 
robustly binds amylopectin, and similar to SEX4 is largely in 
the pellet. Next we sought to define how mutations in the 
aromatic channel affect LSF2 glucan binding. The LSF2 
W136A/F162 A mutant, which has a 99% decrease in specific 
glucan phosphatase activity, shows only a moderate (32%) 
decrease in amylopectin binding (FIG. 17 A). This suggests 
that while the active site is necessary for glucan phosphatase 
activity, other regions primarily determine substrate binding. 
These data are consistent with LSF2 containing additional 
glucan-binding sites distinct from the active site aromatic 
channel. 
Indeed, the maltohexaose-bonnd LSF2 structure revealed 
two additional glucan binding sites >20 A from the active site 
(FIG. 17B). Thus, we hypothesized that one or both of these 
additional glucan-binding sites could functionally replace a 
CBM domain and be critical for the biological activity of 
LSF2. 
One maltohexaose chain is located in a binding pocket 
(Site-2) formed by residues from the DSP domain and CT-
motifon the opposite side of the V-loop -21 A from the active 
site. The maltohexaose chain makes extensive contacts (391 
A2 ) with residues in ~4 and a5 of the DSP as well as the 
carboxy-terminus of the CT-domain (FIGS. 12C,D and 19A). 
The maltohexaose chain wraps aronnd the CT loop, forming 
hydrogen bonds with R153 and R157 and van der Waals 
contact with W180 and M155. As with the active site residues, 
Site-2 residues are highly conserved in LSF2 orthologs (FIG. 
11). To determine the effect ofSite-2 glucan binding on LSF2 
activity, we tested the ability of alanine point mutants as well 
as a C-terminal truncation to dephosphorylate starch granles. 
Alanine mutations ofW180, M155, R153 and R157 resulted 
in decreases of specific glucan phosphatase activity of 
24-50% (FIG.18B). Truncation of the three carboxy-terminal 
residues (ARGT) decreased activity by 46%. All mutant pro-
teins maintained near wild-type pNPP activity indicating that 
the observed effects are specific (FIG. 14B). While mutation 
of Site-2 resulted in a substantial decrease in glucan phos-
phatase activity, we also investigated the effect of Site-2 
mutants on substrate binding. We tested the ability of LSF2 
R157 A, which shows the greatest reduction in specific activ-
ity, to bind amylopectin and found that it displayed a substan-
tial (64%) decrease in amylopectin-binding (FIG.18C). This 
decrease was markedly greater than that observed for the 
W136A/F162A active site mutant (FIG. 17A). These data 
demonstrate that Site-2 functions as a glucan-binding inter-
face and that this binding site is important for the biological 
activity of starch dephosphorylation by LSF2. 
Two additional maltohexaose chains were fonnd in a bind-
ing pocket (Site-3) formed by the CT loop region -23 A from 
the active site. Five glucose moieties from two maltohexaose 
chains (Hex-1 and Hex-2) could be resolved (FIGS. 12E,F 
and 19A). The two chains form a helical structure, reminis-
cent of an amylopectin helix, with a contact area of 338 A2 . 
LSF2 primarily interacts with Hex-1, forming hydrogen 
bonding interactions with K245 and E268 and van der Waal' s 
interactions with F261. As with the active site and Site-2 
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residues, Site-3 residues are highly conserved in LSF2 Janecek (2006)), and are found in the catalytic channel of 
orthologs (FIG. 11). To determine the effect ofSite-3 glucan glycosyl hydrolases (Robert (2005), Koropatkin and Smith 
bindingonLSF2activity, wetestedtheabilityofalaninepoint (2010)). However, a similar glucan-aromatic channel inter-
mutants to dephosphorylate starch granules. Alanine muta- face had not been previously observed in any phosphatase. 
tions of E268, K245, and F261 resulted in decreases of spe- 5 Our crystallography data revealed that the LSF2 active site 
cific glucan phosphatase activity of 35-87% (FIG. 19B). All maintains interactions with all 6 glucose moieties on the 
mutant proteins maintained near wild-type pNPP activity maltohexaose chain, thus indicating that the active site of 
indicating that the observed effects are specific (FIG. 14C). LSF2 combines both a DSP active site and glucan-binding 
Similar with Site-2, we also investigated the effect of Site-3 platform. 
on substrate binding. We found that the Site-3 mutant F261A, 10 Indeed, we identified a link between LSF2 substrate bind-
which shows the greatest reduction in specific activity, ing and catalysis mediated by residue F162. In addition to 
showed the most dramatic (73%) decrease in amylopectin-
binding (FIG. 19C). In comparison to Site-2, Site-3 mutants being a part of the active site aromatic channel, F162 is 
showed greater effects on both substrate binding and specific located at the + 1 position from the catalytic triad residue 
glucan phosphatase activity. 15 D161. Rotation of these residues upon glucan binding is 
To determine the contribution of the individual glucan required for the correct catalytic positioning of D161. This 
binding sites to the overall binding of LSF2, we generated connection suggests an inherent mechanism for phosphate 
combination mutants. The combination of Site-2 and Site-3 recognition that is tied directly to the architecture of the 
mutations, R157 A/F261A, displayed an even more dramatic glucan phosphatase aromatic channel. It is important to note 
(87%) decrease in amylopectin binding, but still retained 20 that this may be a general feature of this enzyme class since 
slight binding (FIG. 19C). Only a mutant combining all three this residue is conserved as an aromatic/long chainhydropho-
sites, F162A/W136A/R157A/F261A, resulted in a protein bic residue in all known glucan phosphatase whereas other 
that possesses no detectable glucan binding (FIG.19C). Thus, phosphatases typically possess short-chain hydrophilic resi-
each of the three glucan-binding sites contributes to substrate dues at this position (VanderKooi (201 0)). 
binding and none of the sites are individually sufficient for 25 Despite similarities with other glucan phosphatases, LSF2 
wild-type levels of glucan binding. Taken together, these data is in fact unique among known glucan phosphatases in that 
demonstrate that rather than requiring a scaffold protein or the enzyme functions independent of a CBM. There has been 
CBM, LSF2 possesses three glucan binding sites in its DSP debate as to whether or not other functionality or possibly 
domain that are each critical for its ability to bind glucans and bridging proteins are required for the glucan phosphatase 
function as a specific glucan phosphatase. 30 activity of LSF2 (Comparot-Moss (201 0), Santelia (2011 )). 
Phosphatases dephosphorylate each of the four organic However, our data clearly establish for the first time that LSF2 
macromolecules: proteins, lipids, nucleic acids, and carbohy- utilizes three glucan binding sites located in the phosphatase 
drates. While previous studies have defined the structural domain for carbohydrate binding. The central function attrib-
bases of phosphatase activity with proteins, lipids, and uted to CBMs is substrate localization, and our data demon-
nucleic acids, the basis for phosphatase-glucan interaction 35 strate that the non-catalytic glucan binding sites identified in 
was previously unknown. Here, we examined the structural the LSF2 structural data adopt this functionality. Mutations of 
and biochemical basis of glucan phosphatase activity by Site-2 and Site-3, the two binding sites located away from the 
determining the crystal structure ofLSF2, providing the first active site, result in dramatic decreases in LSF2 glucan bind-
detailed insights into the mechanism of this important class of ing and dephosphorylation, similar to decreases observed for 
enzymes. 40 CBM mutants of SEX4 and laforin (Ganesh (2004), Wang 
At the LSF2 active site, an integrated network of aromatic and Roach (2004), Gentry (2007)). It should be noted that 
residues forms an extended binding pocket that allows spe- Site-2 and Site-3 both utilize residues from the glucan phos-
cific glucan interaction and dephosphorylation. While these phatase-specific CT motif (Vander Kooi (2010), Santelia 
aromatic residues are within the core DSP domain, in each (2011)). Thus, this unique elaboration on the core phos-
case they are uniquely suited to promote phospho-glucan 45 phatase domain provides novel functionality. 
binding. Conservation of aromatic residues in the active site Carbohydrate active enzymes (CAZymes) as defined by 
between glucan phosphatases suggests that this is a key gen- the CAZy database (http://www.cazy.org) are a diverse col-
era! characteristic differentiating glucan phosphatases from lection of enzymes that synthesize and degrade an extremely 
other phosphatases. It is particularly notable that both LSF2 heterogeneous group of complex carbohydrates and glyco-
and the previously determined SEX4 structure possess an 50 conjugates (Cantarel (2009)). These enzymes cover >250 
a-helical V-loop containing conserved aromatic residues, protein families including glycoside hydrolases, glycosyl-
Y135 and W136 in the LSF2 V-loop (VanderKooi (2010)). transferases, polysaccharide lyases, carbohydrate esterases, 
These residues are integral for LSF2 glucan binding and and non-enzymatic proteins that contain a CBM (Cantarel 
dephosphorylation and form the basis of the conserved theme (2009) ). A CBM is a contiguous amino acid sequence with a 
of an aromatic channel within the active site of glucan phos- 55 conserved tertiary fold that possesses carbohydrate-binding 
phatases. In contrast, the V-loop of PTPs and DSPs are his- ability and is contained within a carbohydrate-modifying 
torically defined by their lack of secondary structure and enzyme (Coutinho and Henrissat (1999), Boraston (2004), 
highly variable length (Alonso (2003)). Phospho-tyrosine Machovic and Janecek (2006); Cantarel (2009)). Many of the 
phosphatases contain longer V-loops when compared to enzymes that synthesize and degrade carbohydrates utilize a 
phospho-serine/threonine phosphatases in order to generate a 60 CBM to bind their carbohydrate substrate and then enzymati-
deeper binding pocket that accommodates the longer phos- cally act on the carbohydrate via a distinct catalytic module. 
pho-tyrosine. However, in each case the V-loop is indeed a Thismodelofabindingdomainandenzymaticdomainistrue 
loop (Alonso (2003), Tonks (2006)). Thus, the glucan phos- for the other identified glucan phosphatases (Worby (2006), 
phatase structured V-loop appears to be a defining character- Gentry (2007), Kotting (2009), VanderKooi (2010)). Indeed, 
istic of this phosphatase class. 65 the glucan phosphatases were originally defined as any pro-
Aromatic-glucose stacking interactions are a central struc- tein containing a phosphatase domain and a CBM (Gentry 
tural element for CBMs (Boraston (2004), Machovic and (2007)). While LSF2 is a carbohydrate-modifying enzyme 
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that binds carbohydrates, it does not contain a classical CBM turing of feedstock for both food and non-food applications 
and is not classified under the CAZy classification. (Santelia and Zeeman (201 0)). Starch is used in countless 
Alternatively, LSF2 utilizes a glucan binding architecture applications, many of which require chemical and physical 
referred to as secondary binding sites (SBSs) (Robert (2005), modifications to improve and diversify its functionality 
Bozonnet (2007), Cuyvers (2011)). SBSs are an emerging 5 (Blennow (2002), Santelia and Zeeman (2010)). Phosphory-
theme found in some glycoside hydrolases (GHs) (Cuyvers lation is the only known natural modification of starch and 
(2011)). Many GHs possess one or more CBM, but recent highly phosphorylated starches have many attractive charac-
structural studies have identified a subset of GHs that contain teristics, including increased hydration status (Muhrbeck and 
both a CBM and SBSs, such as SusG (Koropatkin and Smith Eliasson (1991)), decreased crystallinity (Muhrbeck and 
(201 0)), or that only possess SBSs, such as barley a-amylase 10 Elias son (1991 )), and improved freeze-thaw stability, viscos-
(Kadziola (1998), Robert (2005)), human salivary and pan- ity and transparency (Blennow A (2001 )). Arabidopsis plants 
creatic a-amylase (Pagan and Qian (2003), Ragunath lacking LSF2 activity display increased C3-phosphorylated 
(2008) ), and yeast glucoamylase (Sevcik (2006) ). Indeed, the starch without adverse effects on plant growth (Santelia 
two SBSs of barley a-amylase, which are remote from its (2011 )). Genetic manipulation of LSF2 could therefore rep-
glucan-binding active site, are directly involved in substrate 15 resent a new means to produce starch with higher phosphate 
binding and hydrolysis and these two sites act synergistically content, particularly in cereal crops containing virtually no 
(Nielsen (2009)). covalently bound phosphate (Blennow (2000)). This possi-
These results establish that LSF2 independently binds and bility is further realized through a more complete understand-
dephosphorylates starch. As starch is a complex, insoluble ing ofLSF2 structure and function that can be used to inform 
substrate, the presence of multiple glucan binding interfaces 20 the engineering of glucan phosphatases to alter their function-
may permit LSF2 to uniquely engage the complex multiva- ality for industrial starch processing, particularly in light of 
lent glucan surface of its endogenous substrate. Indeed, the disparities between C6- and C3-contributions to starch super-
combined-sitemutants (R157A/F261 AandF162A/W136A/ structure. Structural insights into the unique mechanism of 
R157 A/F261A) show additive effects, implying that the sites LSF2 are fundamental to our understanding of starch catabo-
function together. This suggests a model whereby starch 25 !ism and ultimately harnessing starch as a biomolecule with 
binding involves the engagement oflonger or multiple glucan diverse applications. 
chains by the three glucan binding sites on LSF2 (FIG. 21). While the terms used herein are believed to be well under-
Moreover, the helical glucan chains at Site-3 are reminiscent stood by one of ordinary skill in the art, the definitions set 
of amylopectin suggesting LSF2 may interact with complex forth herein are provided to facilitate explanation of the pres-
starch granules with distinct helical characteristics. The func- 30 ently-disclosed subject matter. 
tiona! significance of secondary binding sites in glycosyl Unless defined otherwise, all technical and scientific terms 
hydrolases has been extensively reviewed and various addi- used herein have the same meaning as commonly understood 
tiona! functions have been postulated, including substrate by one of ordinary skill in the art to which the presently-
disruption, allosteric regulation, enhancing processivity, and disclosed subject matter belongs. Although any methods, 
relaying of reaction products (Cuyvers (2011 )). On-going 35 devices, and materials similar or equivalent to those described 
studies will examine in more detail the specific role and herein can be used in the practice or testing of the presently-
possible cooperativity of these additional glucan binding sites disclosed subject matter, representative methods, devices, 
of LSF2. and materials are now described. 
These data also give a clearer picture of the role of glucan Following long-standing patent law convention, the terms 
phosphatases in the cyclical starch degradation process. The 40 "a", "an", and "the" refer to "one or more" when used in this 
glucan dikinases phosphorylate the outer glucose moieties of application, including the claims. Thus, for example, refer-
starch at the C6- and C3-positions, resulting in amylopectin ence to "a cell" includes a plurality of such cells, and so forth. 
helix unwinding and local solubilization. These events allow Unless otherwise indicated, all numbers expressing quan-
a- and ~-amylases as well as isoamylases to access the outer tities of ingredients, properties such as reaction conditions, 
glucans and release maltose and malto-oligosaccharides. 45 and so forth used in the specification and claims are to be 
However, ~-amylase activity is inhibited when a phosphate understood as being modified in all instances by the term 
group is reached. The glucan phosphatases bind and dephos- "about". Accordingly, unless indicated to the contrary, the 
phorylate the phospho-glucans to allow further amylolytic numerical parameters set forth in this specification and claims 
activity and a resetting of the starch degradation cycle (FIG. are approximations that can vary depending upon the desired 
21). The coordinated phosphorylation of starch glucose at the 50 properties sought to be obtained by the presently-disclosed 
C6- and C3-position is the central signaling event orchestrat- subject matter. 
ing starch breakdown (Blennow and Engel sen (201 0), Kot- As used herein, the term "about," when referring to a value 
ting (201 0), Streb and Zeeman (2013)). The recent character- or to an amount of mass, weight, time, volume, concentration 
ization of SEX4 and LSF2 illustrates that plants utilize a or percentage is meant to encompass variations of in some 
two-enzyme system for phosphate removal, permitting com- 55 embodiments ±50%, in some embodiments ±40%, in some 
plete starch catabolism. Our structures reveal the basis for the embodiments ±30%, in some embodiments ±20%, in some 
glucan binding and C3-specificity ofLSF2. Determination of embodiments ±1 0%, in some embodiments ±5%, in some 
additional glucan phosphatase structures will reveal further embodiments ±1%, in some embodiments ±0.5%, and in 
insights into the mechanism of activity and specificity of some embodiments ±0.1% from the specified amount, as such 
glucan phosphatases. In particular, it will be interesting to 60 variations are appropriate to perform the disclosed method. 
determine if the presence of a CBM domain in other family As used herein, ranges can be expressed as from "about" 
members not only contributes to substrate binding but also to one particular value, and/or to "about" another particular 
position-specific function. value. It is also understood that there are a number of values 
As the central regulatory event governing starch break- disclosed herein, and that each value is also herein disclosed 
down, modulation of reversible phosphorylation has the 65 as "about" that particular value in addition to the value itself. 
potential to increase starch yields and produce starches with For example, if the value "1 0" is disclosed, then "about 1 0" is 
novel physicochemical properties, thus enhancing manufac- also disclosed. It is also understood that each unit between 
US 9,410,133 Bl 
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two particular units are also disclosed. For example, ifl 0 and 
15 are disclosed, then 11, 12, 13, and 14 are also disclosed. 
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<160> NUMBER OF SEQ ID NOS, 4 
<210> SEQ ID NO 1 
<211> LENGTH, 379 
<212> TYPE, PRT 
US 9,410,133 Bl 
SEQUENCE LISTING 
<213> ORGANISM, Arabidopsis thaliana 
<400> SEQUENCE, 1 
Met Asn Cys Leu Gln Asn Leu Pro Arg Cys Ser Val Ser Pro Leu Leu 
1 5 10 15 
Gly Phe Gly Cys Ile Gln Arg Asp His Ser Ser Ser Ser Ser Ser Leu 
20 25 30 
Lys Met Leu Ile Ser Pro Pro Ile Lys Ala Asn Asp Pro Lys Ser Arg 
35 40 45 
Leu Val Leu His Ala Val Ser Glu Ser Lys Ser Ser Ser Glu Met Arg 
50 55 60 
Gly Val Ala Lys Asp Glu Glu Lys Ser Asp Glu Tyr Ser Gln Asp Met 
65 70 75 80 
Thr Gln Ala Met Gly Ala Val Leu Thr Tyr Arg His Glu Leu Gly Met 
85 90 95 
Asn Tyr Asn Phe Ile Arg Pro Asp Leu Ile Val Gly Ser Cys Leu Gln 
100 105 110 
Thr Pro Glu Asp Val Asp Lys Leu Arg Lys Ile Gly Val Lys Thr Ile 
115 120 125 
Phe Cys Leu Gln Gln Asp Pro Asp Leu Glu Tyr Phe Gly Val Asp Ile 
130 135 140 
Ser Ser Ile Gln Ala Tyr Ala Lys Lys Tyr Ser Asp Ile Gln His Ile 
145 150 155 160 
Arg Cys Glu Ile Arg Asp Phe Asp Ala Phe Asp Leu Arg Met Arg Leu 
165 170 175 
Pro Ala Val Val Gly Thr Leu Tyr Lys Ala Val Lys Arg Asn Gly Gly 
180 185 190 
Val Thr Tyr Val His Cys Thr Ala Gly Met Gly Arg Ala Pro Ala Val 
195 200 205 
Ala Leu Thr Tyr Met Phe Trp Val Gln Gly Tyr Lys Leu Met Glu Ala 
210 215 220 
His Lys Leu Leu Met Ser Lys Arg Ser Cys Phe Pro Lys Leu Asp Ala 
225 230 235 240 
Ile Arg Asn Ala Thr Ile Asp Ile Leu Thr Gly Leu Lys Arg Lys Thr 
245 250 255 
Val Thr Leu Thr Leu Lys Asp Lys Gly Phe Ser Arg Val Glu Ile Ser 
260 265 270 
Gly Leu Asp Ile Gly Trp Gly Gln Arg Ile Pro Leu Thr Leu Gly Lys 
275 280 285 
Gly Thr Gly Phe Trp Ile Leu Lys Arg Glu Leu Pro Glu Gly Gln Phe 
290 295 300 
Glu Tyr Lys Tyr Ile Ile Asp Gly Glu Trp Thr His Asn Glu Ala Glu 
305 310 315 320 
Pro Phe Ile Gly Pro Asn Lys Asp Gly His Thr Asn Asn Tyr Ala Lys 
325 330 335 
Val Val Asp Asp Pro Thr Ser Val Asp Gly Thr Thr Arg Glu Arg Leu 
340 345 350 
Ser Ser Glu Asp Pro Glu Leu Leu Glu Glu Glu Arg Ser Lys Leu Ile 
355 360 365 
42 
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43 
Gln Phe Leu Glu Thr Cys Ser Glu Ala Glu Val 
370 375 
<210> SEQ ID NO 2 
<211> LENGTH, 282 
<212> TYPE, PRT 
<213> ORGANISM, Arabidopsis thaliana 
<400> SEQUENCE, 2 
-continued 
Met Ser Val Ile Gly Ser Lys Ser Cys Ile Phe Ser Val Ala Arg Tyr 
1 5 10 15 
Thr Arg Glu Asn Glu Lys Ser Ser Cys Phe Thr Ser Ile Asn Lys Lys 
20 25 30 
Ser Ser Leu Asp Leu Arg Phe Pro Arg Asn Leu Ala Gly Val Ser Cys 
35 40 45 
Lys Phe Ser Gly Glu Asn Pro Gly Thr Asn Gly Val Ser Leu Ser Ser 
50 55 60 
Lys Asn Lys Met Glu Asp Tyr Asn Thr Ala Met Lys Arg Leu Met Arg 
65 70 75 80 
Ser Pro Tyr Glu Tyr His His Asp Leu Gly Met Asn Tyr Thr Leu Ile 
85 90 95 
Arg Asp Glu Leu Ile Val Gly Ser Gln Pro Gln Lys Pro Glu Asp Ile 
100 105 110 
Asp His Leu Lys Gln Glu Gln Asn Val Ala Tyr Ile Leu Asn Leu Gln 
115 120 125 
Gln Asp Lys Asp Ile Glu Tyr Trp Gly Ile Asp Leu Asp Ser Ile Val 
130 135 140 
Arg Arg Cys Lys Glu Leu Gly Ile Arg His Met Arg Arg Pro Ala Lys 
145 150 155 160 
Asp Phe Asp Pro Leu Ser Leu Arg Ser Gln Leu Pro Lys Ala Val Ser 
165 170 175 
Ser Leu Glu Trp Ala Val Ser Glu Gly Lys Gly Arg Val Tyr Val His 
180 185 190 
Cys Ser Ala Gly Leu Gly Arg Ala Pro Gly Val Ser Ile Ala Tyr Met 
195 200 205 
Tyr Trp Phe Cys Asp Met Asn Leu Asn Thr Ala Tyr Asp Thr Leu Val 
210 215 220 
Ser Lys Arg Pro Cys Gly Pro Asn Lys Gly 
225 230 
Tyr Asp Leu Ala Lys Asn Asp Pro Trp Lys 
245 250 
Pro Glu Asn Ala Phe Glu Asp Ile Ala Asp 
260 265 
Gln Glu Arg Val Arg Ala Leu Arg Gly Thr 
275 280 
<210> SEQ ID NO 3 
<211> LENGTH, 294 
<212> TYPE, PRT 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
Ala Ile Arg Gly Ala 
235 
Glu Pro Phe Glu Ser 
255 
Trp Glu Arg Lys Leu 
270 
Thr 
240 
Leu 
Ile 
<223> OTHER INFORMATION, truncated and modified SEX4 from Arabidopsis 
<400> SEQUENCE, 3 
Gly Ser His Met Tyr Arg His Glu Leu Gly Met Asn Tyr Asn Phe Ile 
1 5 10 15 
Arg Pro Asp Leu Ile Val Gly Ser Cys Leu Gln Thr Pro Glu Asp Val 
44 
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45 
-continued 
20 25 30 
Asp Lys Leu Arg Lys Ile Gly Val Lys Thr Ile Phe Cys Leu Gln Gln 
35 40 45 
Asp Pro Asp Leu Glu Tyr Phe Gly Val Asp Ile Ser Ser Ile Gln Ala 
50 55 60 
Tyr Ala Lys Lys Tyr Ser Asp Ile Gln His Ile Arg Cys Glu Ile Arg 
65 70 75 80 
Asp Phe Asp Ala Phe Asp Leu Arg Met Arg Leu Pro Ala Val Val Gly 
85 90 95 
Thr Leu Tyr Lys Ala Val Lys Arg Asn Gly Gly Val Thr Tyr Val His 
100 105 110 
Cys Thr Ala Gly Met Gly Arg Ala Pro Ala Val Ala Leu Thr Tyr Met 
115 120 125 
Phe Trp Val Gln Gly Tyr Lys Leu Met Glu Ala His Lys Leu Leu Met 
130 135 140 
Ser Lys Arg Ser Cys Phe Pro Lys Leu Asp Ala Ile Arg Asn Ala Thr 
145 150 155 160 
Ile Asp Ile Leu Thr Gly Leu Lys Arg Lys Thr Val Thr Leu Thr Leu 
165 170 175 
Lys Asp Lys Gly Phe Ser Arg Val Glu Ile Ser Gly Leu Asp Ile Gly 
180 185 190 
Trp Gly Gln Arg Ile Pro Leu Thr Leu Gly Lys Gly Thr Gly Phe Trp 
195 200 205 
Ile Leu Lys Arg Glu Leu Pro Glu Gly Gln Phe Glu Tyr Lys Tyr Ile 
210 215 220 
Ile Asp Gly Glu Trp Thr His Asn Glu Ala Glu Pro Phe Ile Gly Pro 
225 230 235 240 
Asn Lys Asp Gly His Thr Asn Asn Tyr Ala Lys Val Val Asp Asp Pro 
245 250 255 
Thr Ser Val Asp Gly Thr Thr Arg Glu Arg Leu Ser Ser Glu Asp Pro 
260 265 270 
Glu Leu Leu Glu Glu Glu Arg Ser Lys Leu Ile Gln Phe Leu Glu Thr 
275 280 285 
Cys Ser Glu Ala Glu Val 
290 
<210> SEQ ID NO 4 
<211> LENGTH, 208 
<212> TYPE, PRT 
<213> ORGANISM, Artificial Sequence 
<220> FEATURE, 
<223> OTHER INFORMATION, truncated and modified LSF2 polypeptid sequence 
<400> SEQUENCE, 4 
Gly Ser His Met Met Arg Ser Pro Tyr Glu Tyr His His Asp Leu Gly 
1 5 10 15 
Met Asn Tyr Thr Leu Ile Arg Asp Glu Leu Ile Val Gly Ser Gln Pro 
20 25 30 
Gln Lys Pro Glu Asp Ile Asp His Leu Lys Gln Glu Gln Asn Val Ala 
35 40 45 
Tyr Ile Leu Asn Leu Gln Gln Asp Lys Asp Ile Glu Tyr Trp Gly Ile 
50 55 60 
Asp Leu Asp Ser Ile Val Arg Arg Cys Lys Glu Leu Gly Ile Arg His 
65 70 75 80 
Met Arg Arg Pro Ala Lys Asp Phe Asp Pro Leu Ser Leu Arg Ser Gln 
46 
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47 48 
-continued 
85 90 95 
Leu Pro Lys Ala Val Ser Ser Leu Glu Trp Ala Val Ser Glu Gly Lys 
100 105 110 
Gly Arg Val Tyr Val His Cys Ser Ala Gly Leu Gly Arg Ala Pro Gly 
115 120 125 
Val Ser Ile Ala Tyr Met Tyr Trp Phe Cys Asp Met Asn Leu Asn Thr 
130 135 140 
Ala Tyr Asp Thr Leu Val Ser Lys Arg Pro Cys Gly Pro Asn Lys Gly 
145 150 155 160 
Ala Ile Arg Gly Ala Thr Tyr Asp Leu Ala Lys Asn Asp Pro Trp Lys 
165 170 175 
Glu Pro Phe Glu Ser Leu Pro Glu Asn Ala Phe Glu Asp Ile Ala Asp 
180 185 190 
Trp Glu Arg Lys Leu Ile Gln Glu Arg Val Arg Ala Leu Arg Gly Thr 
195 200 205 
The invention claimed is: 
1. A glucan phosphatase polypeptide variant comprising 
the sequence of SEQ ID NO: 1 or a fragment thereof having 25 
at least 330 amino acids and at least one amino acid mutation 
selected from the group consisting of Y139A, M204A, 
F235A, K237R, K237N, K237S, W314A, N326A, D328A, 
N332A, T201K, T201S, A202T, M204T, M204A, M204R, 
M204L, G205D, G205S, F235G, Y139A/F167A, W278A/ 30 
W314A, W278A/F167A, N326A/N332A, N332A/K307A, 
A202T/G205D, F235G/K237N, Y139A/F167A/F235A, 
W278A/W314A/F167A, and N326A/N332A/K307A, 
wherein there are 1 to 4 amino acid mutations. 
4. The glucan phosphatase polypeptide variant of claim 1, 
comprising the sequence of a SEQ ID NO: 1 having at least 
one amino acid mutations selected from the group consisting 
of Y139A, M204A, F235A, K237R, K237N, K237S, 
W314A, N326A, D328A, N332A, T201K, T201S, A202T, 
M204T, M204A, M204R, M204L, G205D, G205S, F235G, 
Y139A/F167A, W278A/W314A, W278A/F167A, N326A/ 
N332A, N332A/K307A, A202T/G205D, F235G/K237N, 
Y139A/F167A/F235A, W278A/W314A/F167A, and 
N326A/N332A/K307A, and wherein 1 to 10 amino acids 
have been deleted from theN-terminus and 1 to 20 amino 
2. The glucan phosphatase polypeptide variant of claim 1, 
35 
acids have been deleted from the C-terminus. 
wherein the at least one amino acid mutation is located in a 5. A method of producing starch, comprising: 
Dual Specificity Phosphatase (DSP) domain of the glucan providing a plant that produces a glucan phosphatase 
phosphatase polypeptide. polypeptide variant of claim 1; and 
3. The glucan phosphatase polypeptide variant of claim 1, 
comprising the sequence of SEQ ID NO: 1 having at least one collecting starch from the plant. 
amino acid mutations selected from the group consisting of 40 6. The method of claim 5, wherein the amino acid mutation 
Y139A, M204A, F235A, K237R, K237N, K237s, w314A, is located in a Dual Specificity Phosphatase (DSP) domain of 
N326A, D328A, N332A, T201K, T201S, A202T, M204T, the glucan phosphatase polypeptide. 
M204A, M204R, M204L, G205D, G205S, F235G, Y139A/ 7. The method of claim 5, wherein the plant comprises a 
F167A, W278A/W314A, W278A/F167A, N326A/N332A, nucleotide encoding the glucan phosphatase polypeptide 
N332A/K307 A, A202T/G205D, F235G/K237N, Y139A/ 45 variant. 
p 167 A/F235A, W278A/W314A/F 167 A, and N326A/ 8. A eDNA molecule encoding the polypeptide of claim 1. 
N332A/K307 A. 
* * * * * 
